{"content":"<li class=\"n-box-item date-title\" data-end=\"1490932799\" data-start=\"1490846400\" data-txt=\"Sunday, December 22, 2019\">Thursday, March 30, 2017</li><li class=\"n-box-item sa-box-item\" data-id=\"3254629\" data-ts=\"1490915050\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/P\" target=\"_blank\">P</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3254629-pandora-extends-board-nomination-deadline-yet-again\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pandora extends board nomination deadline yet again</a></h4><ul>   <li>Pandora Media (<a href=\"http://seekingalpha.com/symbol/P\" target=\"_blank\">P</a> <font color='red'>-1.6%</font>) has again <a href=\"https://seekingalpha.com/filing/3481166\" target=\"_blank\">extended a deadline</a> for nominations to its board, with increasing likelihood that it faces a proxy fight.</li>    <li>In a filing, the company says it's amended by-laws to extend the date to April 14. That's after a <a href=\"https://seekingalpha.com/news/3248578-pandora-extends-board-nomination-deadline-shares-2_9-percent\" target=\"_blank\">previous extension to March 17</a> and one <a href=\"https://seekingalpha.com/filing/3464083\" target=\"_blank\">stretching it to March 31</a>.</li>    <li>Recently, founder Tim Westergren has said the company's not for sale and that it will achieve profitability this year.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3254629\" data-linked=\"Pandora extends board nomination deadline yet again\" data-tweet=\"$P - Pandora extends board nomination deadline yet again https://seekingalpha.com/news/3254629-pandora-extends-board-nomination-deadline-yet-again?source=tweet\" data-url=\"https://seekingalpha.com/news/3254629-pandora-extends-board-nomination-deadline-yet-again\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:04 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3254625\" data-ts=\"1490912948\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WIN\" target=\"_blank\">WIN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3254625-windstream-plans-expansion-of-detroit-metro-fiber-network\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Windstream plans expansion of Detroit metro fiber network</a></h4><ul>   <li>Windstream Holdings (<a href=\"http://seekingalpha.com/symbol/WIN\" target=\"_blank\">WIN</a> <font color='green'>+1.9%</font>) is pursuing a \"major\" <a href=\"https://seekingalpha.com/pr/16786393-windstream-expands-metro-fiber-network-detroit\" target=\"_blank\">expansion of its Detroit metro fiber network</a>.</li>    <li>The company's short on details, but the expansion will include fiber along with fixed wireless in order to connect the company's national network with major data-center complexes and commercial buildings in the area.</li>    <li>It's not only expanding the footprint, Windstream says, but also services available, \"including fixed wireless service, unified communications, managed services, network security, business continuity, network solutions and cloud services.\"</li>    <li>Similar expansions are planned for Charlotte, Nashville, Richmond, Little Rock, Atlanta, Chicago, Minneapolis, Philadelphia, Dallas, St. Louis and Cleveland.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3254625\" data-linked=\"Windstream plans expansion of Detroit metro fiber network\" data-tweet=\"$WIN $WINMQ - Windstream plans expansion of Detroit metro fiber network https://seekingalpha.com/news/3254625-windstream-plans-expansion-of-detroit-metro-fiber-network?source=tweet\" data-url=\"https://seekingalpha.com/news/3254625-windstream-plans-expansion-of-detroit-metro-fiber-network\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:29 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3254623\" data-ts=\"1490912259\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FTR\" target=\"_blank\">FTR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3254623-frontier-expands-texas-broadband-offering-25000-households\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Frontier expands Texas broadband offering by 25,000 households</a></h4><ul>   <li>Frontier Communications (<a href=\"http://seekingalpha.com/symbol/FTR\" target=\"_blank\">FTR</a> <font color='green'>+5.5%</font>) says it's leveraged federal funding to help it make enhanced broadband available to <a href=\"https://seekingalpha.com/pr/16786235-frontier-communications-expands-broadband-25000-additional-texas-households\" target=\"_blank\">another 25,000 Texas households</a>.</li>    <li>The company is using the Connect America Fund, designed to subsidize rural broadband, to supply about 5,500 households in eligible census blocks, along with expanded reach to another 20,000 households.</li>    <li>As of last year, Frontier began receiving about $16M annually from the CAF in order to expand Texas locations to 37,208 by the end of 2020.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3254623\" data-linked=\"Frontier expands Texas broadband offering by 25,000 households\" data-tweet=\"$FTR - Frontier expands Texas broadband offering by 25,000 households https://seekingalpha.com/news/3254623-frontier-expands-texas-broadband-offering-25000-households?source=tweet\" data-url=\"https://seekingalpha.com/news/3254623-frontier-expands-texas-broadband-offering-25000-households\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:17 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3254619\" data-ts=\"1490911099\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XSPA\" target=\"_blank\">XSPA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3254619-form-holdingsminus-6-after-fiscal-year-report\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FORM Holdings -6% after fiscal-year report</a></h4><ul>   <li>FORM Holdings (FH) is slipping in the postmarket session, <font color='red'>down 6%</font> after an <a href=\"https://seekingalpha.com/news/3254604-form-holdings-reports-fy-results\" target=\"_blank\">earnings report</a> where IP revenue fell by half but promising new revenue streams came from growth in XpresSpa and Group Mobile.</li>    <li>Fiscal year revenue by segment: XpresSpa, $811K (new); Group Mobile, $6.64M (up 610%); FLI Charge, $350K (up from previous $2K); Intellectual property, $11.18M (down 48.6%).</li>    <li>The company says it plans to grow revenues for recently acquired XpresSpa through store expansion as well as comp store sales increases, while Group Mobile can be grown with new products, new regions and new distribution verticals (including military and government).</li>    <li>For FLI Charge, it expects to enhance IP rights and \"strengthen and develop partnerships in numerous markets including automotive, education, office, healthcare, power tools and vaporizers.\"</li>    <li>Cash balance at Dec. 31 was $17.9M.</li>    <li><a href=\"https://www.sec.gov/Archives/edgar/data/1410428/000114420417017688/v462079_10k.htm\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3254619\" data-linked=\"FORM Holdings -6% after fiscal-year report\" data-tweet=\"$XSPA - FORM Holdings -6% after fiscal-year report https://seekingalpha.com/news/3254619-form-holdingsminus-6-after-fiscal-year-report?source=tweet\" data-url=\"https://seekingalpha.com/news/3254619-form-holdingsminus-6-after-fiscal-year-report\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:58 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3254612\" data-ts=\"1490909874\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3254612-after-hours-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers</a></h4><ul>     <li><b>Top gainers:</b> <a href='https://seekingalpha.com/symbol/CNAT' title='Conatus Pharmaceuticals'>CNAT</a> <font color='green'>+5.4%</font>. NQ <font color='green'>+4.8%</font>. <a href='https://seekingalpha.com/symbol/VJET' title='voxeljet AG'>VJET</a> <font color='green'>+3.5%</font>. <a href='https://seekingalpha.com/symbol/EGLE' title='Eagle Bulk Shipping Inc.'>EGLE</a> <font color='green'>+3.3%</font>. <a href='https://seekingalpha.com/symbol/SUN' title='Sunoco LP'>SUN</a> <font color='green'>+1.9%.</font></li><li><b>Top losers:</b> <a href='https://seekingalpha.com/symbol/PTI' title='Proteostasis Therapeutics'>PTI</a> <font color='red'>-13.2%</font>. <a href='https://seekingalpha.com/symbol/FRSH' title='Papa Murphy&#39;s Holdings, Inc.'>FRSH</a> <font color='red'>-4.6%</font>. <a href='https://seekingalpha.com/symbol/NH' title='NantHealth'>NH</a> <font color='red'>-3.7%</font>. <a href='https://seekingalpha.com/symbol/HPQ' title='HP Inc.'>HPQ</a> <font color='red'>-2.1%</font>. <a href='https://seekingalpha.com/symbol/GGB' title='Gerdau S.A.'>GGB</a> <font color='red'>-1.8%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3254612\" data-linked=\"After Hours Gainers / Losers\" data-tweet=\"$CNAT $LKM $VJET - After Hours Gainers / Losers https://seekingalpha.com/news/3254612-after-hours-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3254612-after-hours-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:37 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3254607\" data-ts=\"1490908275\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VJET\" target=\"_blank\">VJET</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3254607-voxeljetplus-4_9-after-q4-earnings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Voxeljet +4.9% after Q4 earnings</a></h4><ul>   <li>Voxeljet (NYSE:<a href='https://seekingalpha.com/symbol/VJET' title='voxeljet AG'>VJET</a>) is <font color='green'>up 4.9%</font> following a <a href=\"https://seekingalpha.com/news/3254578-voxeljet-ag-reports-q4-results\" target=\"_blank\">Q4 report</a> where revenues dipped and missed, but the company stuck to its forecast for full-year sales.</li>    <li>Revenue of &euro;6.28M missed an expected &euro;6.83M. Systems revenues fell 19.7%, to &euro;3.93M, while services revenues dropped 30.7% to &euro;2.34M.</li>    <li>Gross profit, meanwhile, was up in Services (to &euro;875K from a loss of &euro;337K), and down in Systems (to &euro;379K from &euro;2M).</li>    <li>Backlog of 3D printer orders at Dec. 31 was &euro;3.78M -- representing five printers. That's vs. a backlog of &euro;5.6M (nine printers) the prior year.</li>    <li>Cash and equivalents at year's end were &euro;7.85M and the company had &euro;12.58M in bond funds and a note receivable.</li>    <li>For Q1, the company's guiding to revenue of &euro;4.25M-&euro;4.75M, and it reaffirms full-year guidance for revenues of &euro;26M-&euro;28M, gross margin over 40%, capex of &euro;8M-&euro;9M and EBITDA neutral to positive.</li>    <li><a href=\"https://event.webcasts.com/starthere.jsp?ei=1134324\" target=\"_blank\">Conference call</a> to come tomorrow at 8:30 a.m. ET.</li>    <li><a href=\"https://seekingalpha.com/pr/16786343-voxeljet-ag-reports-financial-results-fourth-quarter-full-year-ended-december-31-2016\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3254607\" data-linked=\"Voxeljet +4.9% after Q4 earnings\" data-tweet=\"$VJET - Voxeljet +4.9% after Q4 earnings https://seekingalpha.com/news/3254607-voxeljetplus-4_9-after-q4-earnings?source=tweet\" data-url=\"https://seekingalpha.com/news/3254607-voxeljetplus-4_9-after-q4-earnings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:11 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3254597\" data-ts=\"1490906922\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CTSO\" target=\"_blank\">CTSO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3254597-cytosorbents-slides-9-on-capital-raise\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cytosorbents slides 9% on capital raise</a></h4><ul><li>The size of the <a href=\"https://seekingalpha.com/pr/16786279-cytosorbents-announces-proposed-offering-common-stock\" target=\"_blank\">share sale</a> isn't disclosed. Cowen is the sole underwriter.</li><li><a href='https://seekingalpha.com/symbol/CTSO' title='Cytosorbents Corp'>CTSO</a>&nbsp;<font color='red'>-9.1%</font>&nbsp;after hours</li></ul><div class=\"tiny-share-widget\" data-id=\"3254597\" data-linked=\"Cytosorbents slides 9% on capital raise\" data-tweet=\"$CTSO - Cytosorbents slides 9% on capital raise https://seekingalpha.com/news/3254597-cytosorbents-slides-9-on-capital-raise?source=tweet\" data-url=\"https://seekingalpha.com/news/3254597-cytosorbents-slides-9-on-capital-raise\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:48 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3254595\" data-ts=\"1490906639\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PSTI\" target=\"_blank\">PSTI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3254595-pluristemplus-5-talks-for-japan-jv-progress\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pluristem +5% as talks for Japan JV progress</a></h4><ul><li>Pluristem Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/PSTI' title='Pluristem Therapeutics, Inc.'>PSTI</a>) gets <a href=\"https://seekingalpha.com/pr/16786277-pluristem-sosei-cvc-advancing-towards-finalizing-joint-venture-commercialization-plx-pad\" target=\"_blank\">closer towards the formation</a> of a new corporation with&nbsp;Sosei Corporate Venture Capital to pursue development and commercialization of the PLX-PAD cell therapy product in Japan.</li><li>A definitive deal should be announced in coming months, rather than by March 31 as previously announced.</li><li>Shares&nbsp;<font color='green'>+5%</font>&nbsp;after hours</li></ul><div class=\"tiny-share-widget\" data-id=\"3254595\" data-linked=\"Pluristem +5% as talks for Japan JV progress\" data-tweet=\"$PSTI - Pluristem +5% as talks for Japan JV progress https://seekingalpha.com/news/3254595-pluristemplus-5-talks-for-japan-jv-progress?source=tweet\" data-url=\"https://seekingalpha.com/news/3254595-pluristemplus-5-talks-for-japan-jv-progress\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:43 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3254592\" data-ts=\"1490906287\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BTX\" target=\"_blank\">BTX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3254592-positive-coverage-lifts-biotime-and-macrogenics-post-close\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Positive coverage lifts BioTime and MacroGenics post-close</a></h4><ul><li>Volume isn't huge, but BioTime (NYSEMKT:<a href='https://seekingalpha.com/symbol/BTX' title='BioTime, Inc'>BTX</a>) is&nbsp;<font color='green'>higher by 3.9%</font>, and MacroGenics (NASDAQ:<a href='https://seekingalpha.com/symbol/MGNX' title='MacroGenics, Inc.'>MGNX</a>)&nbsp;<font color='green'>by 1.5%</font>&nbsp;after Raymond James initiates coverage on both with Outperform ratings.</li><li>The $6 price target on BTX suggests more than&nbsp;<font color='green'>80% upside</font>, and the $26 price target on MGNX suggests nearly&nbsp;<font color='green'>50% upside</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3254592\" data-linked=\"Positive coverage lifts BioTime and MacroGenics post-close\" data-tweet=\"$BTX $LCTX $MGNX - Positive coverage lifts BioTime and MacroGenics post-close https://seekingalpha.com/news/3254592-positive-coverage-lifts-biotime-and-macrogenics-post-close?source=tweet\" data-url=\"https://seekingalpha.com/news/3254592-positive-coverage-lifts-biotime-and-macrogenics-post-close\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:38 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3254588\" data-ts=\"1490906040\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AKTX\" target=\"_blank\">AKTX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3254588-akari-therapeutics-gains-8-on-fast-track-status-for-coversin\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Akari Therapeutics gains more than 8% on Fast Track status for Coversin</a></h4><ul><li>The company's Coversin&nbsp;for treatment of paroxysmal nocturnal hemoglobinuria in patients who have polymorphisms conferring eculizumab resistance <a href=\"https://seekingalpha.com/pr/16786292-akari-therapeutics-announces-fda-fast-track-designation-coversin\" target=\"_blank\">has won</a> Fast Track designation by the FDA.</li><li><a href='https://seekingalpha.com/symbol/AKTX' title='Akari Therapeutics Plc'>AKTX</a>&nbsp;<font color='green'>+8.7</font>% after hours</li></ul><div class=\"tiny-share-widget\" data-id=\"3254588\" data-linked=\"Akari Therapeutics gains more than 8% on Fast Track status for Coversin\" data-tweet=\"$AKTX - Akari Therapeutics gains more than 8% on Fast Track status for Coversin https://seekingalpha.com/news/3254588-akari-therapeutics-gains-8-on-fast-track-status-for-coversin?source=tweet\" data-url=\"https://seekingalpha.com/news/3254588-akari-therapeutics-gains-8-on-fast-track-status-for-coversin\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:34 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3254587\" data-ts=\"1490905860\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DRIO\" target=\"_blank\">DRIO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3254587-dariohealth-tumbles-17-on-share-sale\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">DarioHealth tumbles 17% on share sale</a></h4><ul><li>Aegis Capital is the underwriter, and the <a href=\"https://seekingalpha.com/pr/16786355-dariohealth-corp-announces-proposed-public-offering-common-stock\" target=\"_blank\">size of the capital raise</a> isn't disclosed.</li><li><a href='https://seekingalpha.com/symbol/DRIO' title='DarioHealth Corp.'>DRIO</a><font color='red'> -17%</font>&nbsp;after hours</li></ul><div class=\"tiny-share-widget\" data-id=\"3254587\" data-linked=\"DarioHealth tumbles 17% on share sale\" data-tweet=\"$DRIO - DarioHealth tumbles 17% on share sale https://seekingalpha.com/news/3254587-dariohealth-tumbles-17-on-share-sale?source=tweet\" data-url=\"https://seekingalpha.com/news/3254587-dariohealth-tumbles-17-on-share-sale\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:31 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3254584\" data-ts=\"1490905692\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OREX\" target=\"_blank\">OREX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3254584-orex-therapeuticsminus-7_2-on-capital-raise-plan\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Orex Therapeutics -7.2% on capital raise plan</a></h4><ul><li>With underwriter Cantor Fitzgerald, the company <a href=\"https://www.sec.gov/Archives/edgar/data/1382911/000119312517104041/d339710d8k.htm\" target=\"_blank\">sets an ATM offering</a> for up to $20M of stock.</li><li><a href='https://seekingalpha.com/symbol/OREX' title='Orexigen Therapeutics, Inc.'>OREX</a>&nbsp;<font color='red'>-7.2%</font>&nbsp;after hours</li></ul><div class=\"tiny-share-widget\" data-id=\"3254584\" data-linked=\"Orex Therapeutics -7.2% on capital raise plan\" data-tweet=\"$OREX - Orex Therapeutics -7.2% on capital raise plan https://seekingalpha.com/news/3254584-orex-therapeuticsminus-7_2-on-capital-raise-plan?source=tweet\" data-url=\"https://seekingalpha.com/news/3254584-orex-therapeuticsminus-7_2-on-capital-raise-plan\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:28 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3254575\" data-ts=\"1490905013\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TTPH\" target=\"_blank\">TTPH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3254575-tetraphase-pharmaplus-1_25-after-research-funding\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tetraphase Pharma +1.25% after research funding</a></h4><ul><li>Tetraphase Pharmaceuticals' (NASDAQ:<a href='https://seekingalpha.com/symbol/TTPH' title='Tetraphase Pharmaceuticals'>TTPH</a>) pipeline candidate TP-6076 was <a href=\"https://seekingalpha.com/pr/16786290-tetraphase-pharmaceuticals-tpminus-6076-selected-carb-x-receive-4-million-research-funding\" target=\"_blank\">selected to receive</a> $4M in research funding from the&nbsp;Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator (CARB-X).</li><li>Tetraphase CEO Guy Macdonald notes the \"exceptional in vitro potency against two of the most dangerous organisms, carbapenem-resistant Enterobacteriaceae &#40;CRE&#41; and carbapenem-resistant Acinetobacter baumannii &#40;CRAB&#41;.\"</li><li>Shares&nbsp;<font color='green'>+1.25%</font>&nbsp;after hours</li></ul><div class=\"tiny-share-widget\" data-id=\"3254575\" data-linked=\"Tetraphase Pharma +1.25% after research funding\" data-tweet=\"$TTPH - Tetraphase Pharma +1.25% after research funding https://seekingalpha.com/news/3254575-tetraphase-pharmaplus-1_25-after-research-funding?source=tweet\" data-url=\"https://seekingalpha.com/news/3254575-tetraphase-pharmaplus-1_25-after-research-funding\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:16 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3254571\" data-ts=\"1490904766\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BLRX\" target=\"_blank\">BLRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3254571-biolinerxminus-14-on-capital-raise\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BioLineRx -14% on capital raise</a></h4><ul><li>The company announces <a href=\"https://seekingalpha.com/pr/16786281-biolinerx-announces-underwritten-public-offering-american-depositary-shares\" target=\"_blank\">a secondary offering</a> of ADSs, with JMP Securities underwriting.</li><li><a href='https://seekingalpha.com/symbol/BLRX' title='BioLineRx Ltd.'>BLRX</a>&nbsp;<font color='red'>-14%</font>&nbsp;after hours</li></ul><div class=\"tiny-share-widget\" data-id=\"3254571\" data-linked=\"BioLineRx -14% on capital raise\" data-tweet=\"$BLRX - BioLineRx -14% on capital raise https://seekingalpha.com/news/3254571-biolinerxminus-14-on-capital-raise?source=tweet\" data-url=\"https://seekingalpha.com/news/3254571-biolinerxminus-14-on-capital-raise\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:12 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>20&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3254569\" data-ts=\"1490904673\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UNXL\" target=\"_blank\">UNXL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3254569-uni-pixel-misses-0_05-revenue-in-line\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Uni-Pixel misses by $0.05,  revenue in-line</a></h4><ul><li>Uni-Pixel (NASDAQ:<a href='https://seekingalpha.com/symbol/UNXL' title='Uni-Pixel, Inc.'>UNXL</a>): Q4 EPS of -$0.16 <font color='red'>misses by $0.05</font>.</li><li>Revenue of $1.4M (+57.3% Y/Y) in-line.</li><li>Shares <font color='green'>+1.65%</font>.</li><li><a href='https://seekingalpha.com/pr/16786308-unipixel-reports-year-end-fourth-quarter-2016-financial-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3254569\" data-linked=\"Uni-Pixel misses by $0.05,  revenue in-line\" data-tweet=\"$UNXL - Uni-Pixel misses by $0.05, revenue in-line https://seekingalpha.com/news/3254569-uni-pixel-misses-0_05-revenue-in-line?source=tweet\" data-url=\"https://seekingalpha.com/news/3254569-uni-pixel-misses-0_05-revenue-in-line\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:11 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3254558\" data-ts=\"1490903927\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FCX\" target=\"_blank\">FCX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3254558-workers-to-end-strike-freeport-mcmorans-top-peru-copper-mine\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Workers to end strike at Freeport McMoRan&#39;s top Peru copper mine</a></h4><ul>     <li>Workers at Freeport McMoRan's (<a href='https://seekingalpha.com/symbol/FCX' title='Freeport-McMoRan Inc.'>FCX</a> <font color='green'>+4.6%</font>) Cerro Verde copper mine in Peru will resume work on Friday after <a href=\"http://www.reuters.com/article/peru-copper-strike-idUSL2N1H71BO\" target=\"_blank\">voting to end a nearly three-week strike</a>, the union says.</li>     <li>The union claims the strike has disrupted the mine's production of ~40K metric tons/month of copper, although FCX has said there was no material impact on production.</li>     <li>The news comes amid increased hopes that FCX soon <a href=\"https://seekingalpha.com/news/3254486-freeport-mcmoran-may-nearing-export-deal-indonesia-shares-plus-5-percent\" target=\"_blank\">could resume exports</a> from its Grasberg copper mine in Indonesia.</li></ul><div class=\"tiny-share-widget\" data-id=\"3254558\" data-linked=\"Workers to end strike at Freeport McMoRan&#39;s top Peru copper mine\" data-tweet=\"$FCX - Workers to end strike at Freeport McMoRan&#39;s top Peru copper mine https://seekingalpha.com/news/3254558-workers-to-end-strike-freeport-mcmorans-top-peru-copper-mine?source=tweet\" data-url=\"https://seekingalpha.com/news/3254558-workers-to-end-strike-freeport-mcmorans-top-peru-copper-mine\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:58 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3254554\" data-ts=\"1490903231\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TGNA\" target=\"_blank\">TGNA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3254554-fcc-to-vote-on-reversing-station-ownership-rules\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FCC to vote on reversing station-ownership rules</a></h4><ul>   <li>The FCC will vote in April on another Obama-era reversal, to effectively overturn <a href=\"http://www.reuters.com/article/us-fcc-regulations-tv-idUSKBN1712UD\" target=\"_blank\">limits on the number of TV stations</a> that some companies can buy.</li>    <li>Rules set last year didn't require any company to sell existing stations, but could slow some anticipated acquisitions -- notably a megadeal combo of Sinclair Broadcast Group (<a href=\"http://seekingalpha.com/symbol/SBGI\" target=\"_blank\">SBGI</a> <font color='green'>+2.4%</font>) and rival broadcaster Tribune Media (<a href=\"http://seekingalpha.com/symbol/TRCO\" target=\"_blank\">TRCO</a> <font color='green'>+0.8%</font>).</li>    <li>Chairman Ajit Pai is offering a plan to bring back the \"UHF Discount\" used in calculating station counts for the limit. Before it was revoked last year, the discount let station groups half-count UHF stations (those higher than channel 13 on the old frequency dial).</li>    <li>The FCC had killed the discount on the logic that the old VHF-UHF comparison on strength was moot after the digital TV conversion.</li>    <li>Also moving: <a href='https://seekingalpha.com/symbol/TGNA' title='TEGNA'>TGNA</a> <font color='green'>+0.8%</font>; <a href='https://seekingalpha.com/symbol/NXST' title='Nexstar Media Group, Inc.'>NXST</a> <font color='green'>+2.3%</font>; <a href='https://seekingalpha.com/symbol/CBS' title='CBS Corporation'>CBS</a> <font color='green'>+1.7%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3254554\" data-linked=\"FCC to vote on reversing station-ownership rules\" data-tweet=\"$TGNA $TGNA $NXST - FCC to vote on reversing station-ownership rules https://seekingalpha.com/news/3254554-fcc-to-vote-on-reversing-station-ownership-rules?source=tweet\" data-url=\"https://seekingalpha.com/news/3254554-fcc-to-vote-on-reversing-station-ownership-rules\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:47 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3254552\" data-ts=\"1490902595\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GPN\" target=\"_blank\">GPN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3254552-global-payments-hits-all-time-high-barclays-goes-overweight\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Global Payments hits all-time high as Barclays goes Overweight</a></h4><ul>    <li>Global Payments (NYSE:<a href='https://seekingalpha.com/symbol/GPN' title='Global Payments Inc.'>GPN</a>) is <font color='green'>up 2.5%</font> today and hit an all-time high following a boost to Overweight from Barclays.</li>    <li>Analyst Darrin Peller says the company will post \"cleaner\" organic growth in Q2, and beat expectations for a 90-basis point margin expansion.</li>    <li>It could also beat and raise on expectations of 20% EPS growth.</li>    <li>Among Peller's reasons: Lower attrition and synergies at Heartland, possible M&amp;A (in 2018, or otherwise buying back stock), and better currency comparisons.</li>    <li>He boosted his price target on shares to $92 from $88, implying 14% upside from current levels.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3254552\" data-linked=\"Global Payments hits all-time high as Barclays goes Overweight\" data-tweet=\"$GPN - Global Payments hits all-time high as Barclays goes Overweight https://seekingalpha.com/news/3254552-global-payments-hits-all-time-high-barclays-goes-overweight?source=tweet\" data-url=\"https://seekingalpha.com/news/3254552-global-payments-hits-all-time-high-barclays-goes-overweight\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:36 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3254540\" data-ts=\"1490899233\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BSET\" target=\"_blank\">BSET</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3254540-on-bassett-furnitures-fq1\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Bassett Furniture&#39;s FQ1</a></h4><ul>     <li>Bassett Furniture (<a href='https://seekingalpha.com/symbol/BSET' title='Bassett Furniture Industries, Incorporated'>BSET</a> <font color='red'>-1.3%</font>) reports comparable-store sales rose 1% in <a href=\"https://seekingalpha.com/pr/16785640-bassett-announces-fiscal-first-quarter-results\" target=\"_blank\">FQ1</a>.</li>     <li>Wholesale segment revenue grew 4% to $62M.</li>     <li>Retail segment revenue increased 5.5% to $61.6M.</li>     <li>Logistical services revenue dropped 9.7% to $22.3M.</li>     <li>The gross margin rate fell 30 bps to 60.4%.</li>     <li>Operating margin rate down 100 bps to 4.4%.</li>     <li>Store Count -1 Q/Q to 89.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3254540\" data-linked=\"More on Bassett Furniture&#39;s FQ1\" data-tweet=\"$BSET - More on Bassett Furniture&#39;s FQ1 https://seekingalpha.com/news/3254540-on-bassett-furnitures-fq1?source=tweet\" data-url=\"https://seekingalpha.com/news/3254540-on-bassett-furnitures-fq1\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:40 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3254539\" data-ts=\"1490898967\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3254539-technology-top-gainers-losers-of-2-30-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top Gainers / Losers as of 2:30 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/EXTR' title='Extreme Networks, Inc.'>EXTR</a> <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/VHC' title='VirnetX Holding Corporation'>VHC</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/PCTI' title='PCTEL, Inc.'>PCTI</a> <font color='green'>+11%</font>. NQ <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/NIHD' title='NII Holdings, Inc.'>NIHD</a> <font color='green'>+9%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/IDN' title='Intellicheck Mobilisa, Inc.'>IDN</a> <font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/SAIC' title='Science Applications International Corporation'>SAIC</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/EXFO' title='EXFO Inc.'>EXFO</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/FIVN' title='Five9, Inc.'>FIVN</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/HIMX' title='Himax Technologies, Inc.'>HIMX</a> <font color='red'>-7%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3254539\" data-linked=\"Technology - Top Gainers / Losers as of 2:30 pm\" data-tweet=\"$EXTR $VHC $PCTI - Technology - Top Gainers / Losers as of 2:30 pm https://seekingalpha.com/news/3254539-technology-top-gainers-losers-of-2-30-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3254539-technology-top-gainers-losers-of-2-30-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:36 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>19&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3254538\" data-ts=\"1490898818\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MNST\" target=\"_blank\">MNST</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3254538-monsters-hydro-product-delayed-wells-fargo\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Monster&#39;s Hydro product delayed - Wells Fargo</a></h4><ul><li>Monster Beverage (<a href='https://seekingalpha.com/symbol/MNST' title='Monster Beverage Corp.'>MNST</a> <font color='red'>-1.8%</font>) sinks further for the session on a Wells Fargo note saying its new Hydro product has been delayed, potentially indefinitely.</li><li>Wells: \"We have concerns about the ability for Monster&rsquo;s new innovation to have any meaningful impact on sales this year.\"</li><li><a href=\"https://twitter.com/thenotablecalls\" target=\"_blank\">via Notable Calls</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3254538\" data-linked=\"Monster&#39;s Hydro product delayed - Wells Fargo\" data-tweet=\"$MNST - Monster&#39;s Hydro product delayed - Wells Fargo https://seekingalpha.com/news/3254538-monsters-hydro-product-delayed-wells-fargo?source=tweet\" data-url=\"https://seekingalpha.com/news/3254538-monsters-hydro-product-delayed-wells-fargo\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:33 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3254533\" data-ts=\"1490896904\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3254533-energy-materials-top-gainers-losers-of-2-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials - Top Gainers / Losers as of 2:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/BCEI' title='Bonanza Creek Energy'>BCEI</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/COP' title='ConocoPhillips'>COP</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/FCX' title='Freeport-McMoRan Inc.'>FCX</a> <font color='green'>+5%</font>. <a href='https://seekingalpha.com/symbol/SAEX' title='SAExploration Holdings, Inc.'>SAEX</a> <font color='green'>+5%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/CVE' title='Cenovus Energy, Inc.'>CVE</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/GEVO' title='Gevo, Inc.'>GEVO</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/WOR' title='Worthington Industries, Inc.'>WOR</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/GBR' title='New Concept Energy, Inc.'>GBR</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/MBII' title='Marrone Bio Innovations, Inc.'>MBII</a> <font color='red'>-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3254533\" data-linked=\"Energy/Materials - Top Gainers / Losers as of 2:00 pm\" data-tweet=\"$BCEI $COP $FCX - Energy/Materials - Top Gainers / Losers as of 2:00 pm https://seekingalpha.com/news/3254533-energy-materials-top-gainers-losers-of-2-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3254533-energy-materials-top-gainers-losers-of-2-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3254530\" data-ts=\"1490896444\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EXTR\" target=\"_blank\">EXTR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3254530-analysts-boost-targets-on-extreme-networks-now-up-19-after-brocade-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Analysts boost targets on Extreme Networks, now up 19% after Brocade deal</a></h4><ul>   <li>Extreme Networks (NASDAQ:<a href='https://seekingalpha.com/symbol/EXTR' title='Extreme Networks, Inc.'>EXTR</a>) zoomed in postmarket trade yesterday after news it was <a href=\"https://seekingalpha.com/news/3254297-extreme-networks-buying-brocade-data-center-networking-shares-plus-14-percent\" target=\"_blank\">buying Brocade's data-center networking business</a>, and it's <font color='green'>up a healthy 19%</font> to its highest point in more than 10 years as analysts boost targets.</li>    <li>A $55M cash purchase will generate more than $230M in incremental annualized revenue, Extreme says -- a bargain that made sense for Broadcom/Brocade since it would supply many of the parts for the business, as Wunderlich notes.</li>    <li>Extreme is \"the <a href=\"http://blogs.barrons.com/techtraderdaily/2017/03/30/extreme-next-great-networking-company-targets-zoom-on-broadcom-deal/\" target=\"_blank\">next major networking player</a>,\" says Wunderlich's Matthew Robison, who has boosted his price target to $9 from $8 (implying 18% upside from today's elevated pricing).</li>    <li>Needham has a $9.50 price target, up from $7, noting the deal \"paves the way for the company to be a competitive player in the large enterprise data center market, including edge routing.\"</li> </ul><div class=\"tiny-share-widget\" data-id=\"3254530\" data-linked=\"Analysts boost targets on Extreme Networks, now up 19% after Brocade deal\" data-tweet=\"$EXTR - Analysts boost targets on Extreme Networks, now up 19% after Brocade deal https://seekingalpha.com/news/3254530-analysts-boost-targets-on-extreme-networks-now-up-19-after-brocade-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3254530-analysts-boost-targets-on-extreme-networks-now-up-19-after-brocade-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:54 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3254525\" data-ts=\"1490894142\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SSI\" target=\"_blank\">SSI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3254525-stage-stores-rallies-after-striking-deal-for-gordmans-stores\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Stage Stores rallies after striking deal for Gordmans Stores</a></h4><ul> <li>Stage Stores (<a href='https://seekingalpha.com/symbol/SSI' title='Stage Stores, Inc.'>SSI</a> <font color='green'>+9.3%</font>) announces that it will acquire select assets of Gordmans Stores out of bankruptcy.</li>     <li>Under the terms of the transaction, a Stage subsidiary acquire a minimum of 50 Gordmans store leases, with rights to assume       leases for an additional seven stores and a distribution center.</li><li>The company intends to fund the transaction and related       investments from existing cash and availability under its credit       facility.</li><li>&ldquo;We believe the Gordmans business model offers great       potential and, without the burden of a high level of debt, unprofitable       locations and an oversized infrastructure, we expect the Gordmans       business will be accretive to our earnings,\" says Stage CEO Michael Glazer.</li><li>Source: <a href=\"https://seekingalpha.com/pr/16786083-stage-stores-acquire-selected-assets-gordmans\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3254525\" data-linked=\"Stage Stores rallies after striking deal for Gordmans Stores\" data-tweet=\"$SSI - Stage Stores rallies after striking deal for Gordmans Stores https://seekingalpha.com/news/3254525-stage-stores-rallies-after-striking-deal-for-gordmans-stores?source=tweet\" data-url=\"https://seekingalpha.com/news/3254525-stage-stores-rallies-after-striking-deal-for-gordmans-stores\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:15 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3254520\" data-ts=\"1490893003\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GVA\" target=\"_blank\">GVA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3254520-california-transportation-bill-spark-granite-construction-analyst-says\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">California transportation bill could spark Granite Construction, analyst says</a></h4><ul>     <li>Granite Construction (<a href='https://seekingalpha.com/symbol/GVA' title='Granite Construction, Inc.'>GVA</a> <font color='green'>+4%</font>) is higher following a positive note from Cowen analyst Joseph Giordano, who thinks a California transportation bill <a href=\"http://thefly.com/landingPageNews.php?id=2527373&amp;headline=GVA-California-bill-could-return-momentum-to-Granite-Construction-says-Cowen\" target=\"_blank\">could restore momentum</a> in the shares.</li><li>Giordano says California Gov. Brown and state legislative leaders have set a deadline of April 6 to pass transportation funding bill that could bring a roughly tripling of the  budget increase to the California Department of Transportation, GVA's largest customer, according to TheFly.com.</li><li>GVA rallied post-election but has since reversed even as a California bill is poised to be passed, but Giordano thinks clarity in California  could help the stock; Cowen rates GVA at Outperform with a $70 price target.</li></ul><div class=\"tiny-share-widget\" data-id=\"3254520\" data-linked=\"California transportation bill could spark Granite Construction, analyst says\" data-tweet=\"$GVA - California transportation bill could spark Granite Construction, analyst says https://seekingalpha.com/news/3254520-california-transportation-bill-spark-granite-construction-analyst-says?source=tweet\" data-url=\"https://seekingalpha.com/news/3254520-california-transportation-bill-spark-granite-construction-analyst-says\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:56 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3254517\" data-ts=\"1490892337\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FTR\" target=\"_blank\">FTR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3254517-frontier-communicationsplus-5-in-rebound\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Frontier Communications +5% in rebound</a></h4><ul>   <li>Frontier Communications (NYSE:<a href='https://seekingalpha.com/symbol/FTR' title='Frontier Communications Corporation'>FTR</a>) -- recently in the doldrums after a Goldman Sachs <a href=\"https://seekingalpha.com/news/3252685-frontier-minus-5-percent-goldman-cuts-sell\" target=\"_blank\">downgrade</a> and its <a href=\"https://seekingalpha.com/news/3250626-frontier-communications-minus-2_6-percent-s-and-p-500-ouster\" target=\"_blank\">ouster from the S&amp;P 500</a> -- is <font color='green'>up 5%</font> today with a number of big block trades coming in.</li>    <li>Volume overall has surpassed 33M, vs. a recent daily average of 58.3M.</li>    <li>The company has <a href=\"https://seekingalpha.com/filing/3479770\" target=\"_blank\">amended its June 2014 credit agreement</a> with additions providing that interest rate margins under its facilities will range from 0.875% to 3.875% for base-rate borrowings, and from 1.875% to 4.875% for Libor borrowings.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3254517\" data-linked=\"Frontier Communications +5% in rebound\" data-tweet=\"$FTR - Frontier Communications +5% in rebound https://seekingalpha.com/news/3254517-frontier-communicationsplus-5-in-rebound?source=tweet\" data-url=\"https://seekingalpha.com/news/3254517-frontier-communicationsplus-5-in-rebound\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:45 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>17&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3254516\" data-ts=\"1490892324\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3254516-midday-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/PRAN' title='Prana Biotechnology Ltd'>PRAN</a> <font color='green'>+38%</font>. <a href='https://seekingalpha.com/symbol/ATHX' title='Athersys, Inc.'>ATHX</a> <font color='green'>+25%</font>. <a href='https://seekingalpha.com/symbol/XBIO' title='Xenetic Biosciences, Inc.'>XBIO</a> <font color='green'>+23%</font>. <a href='https://seekingalpha.com/symbol/LPTH' title='LightPath Technologies, Inc.'>LPTH</a> <font color='green'>+20%</font>. <a href='https://seekingalpha.com/symbol/EXTR' title='Extreme Networks, Inc.'>EXTR</a> <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/CVGI' title='Commercial Vehicle Group, Inc.'>CVGI</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/XELB' title='Xcel Brands, Inc.'>XELB</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/BVXV' title='Biondvax Pharmaceuticals'>BVXV</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/ACST' title='Acasti Pharma, Inc.'>ACST</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/IDXG' title='Interpace Diagnostics Group, Inc.'>IDXG</a> <font color='green'>+11%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/CRTN' title='Cartesian, Inc.'>OTC:CRTN</a> <font color='red'>-28%</font>. <a href='https://seekingalpha.com/symbol/LULU' title='Lululemon Athletica Inc.'>LULU</a> <font color='red'>-23%</font>. <a href='https://seekingalpha.com/symbol/TNXP' title='Tonix Pharmaceuticals Holding Corp.'>TNXP</a> <font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/IDN' title='Intellicheck Mobilisa, Inc.'>IDN</a> <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/EXFO' title='EXFO Inc.'>EXFO</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/SAIC' title='Science Applications International Corporation'>SAIC</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/CVE' title='Cenovus Energy, Inc.'>CVE</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/HALO' title='Halozyme Therapeutics, Inc.'>HALO</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/KBSF' title='KBS Fashion Group Limited'>KBSF</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/ROSG-OLD' title='Rosetta Genomics Ltd.'>ROSG-OLD</a> <font color='red'>-10%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3254516\" data-linked=\"Midday Gainers / Losers\" data-tweet=\"$ATHE $ATHX $XBIO - Midday Gainers / Losers https://seekingalpha.com/news/3254516-midday-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3254516-midday-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:45 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3254515\" data-ts=\"1490892298\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IONS\" target=\"_blank\">IONS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3254515-ionis-pharmas-akcea-launches-mid-stage-study-of-dyslipidemia-candidate-to-identify-dosage\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ionis Pharma&#39;s Akcea launches mid-stage study of dyslipidemia candidate to identify dosage regimen for late-stage cardiovascular outcomes study; shares ahead 3%</a></h4><ul><li>Ionis Pharmaceuticals' (<a href='https://seekingalpha.com/symbol/IONS' title='Ionis Pharmaceuticals, Inc.'>IONS</a> <font color='green'>+3%</font>) Akcea Therapeutics <a href=\"https://seekingalpha.com/pr/16785286-akcea-initiates-phase-2-study-akcea-apo-l-rx-patients-high-lp-cardiovascular-disease\" target=\"_blank\">initiates </a>a 270-subject Phase 2b dose-ranging study of AKCEA-APO(a)-Lrx in patients with hyperlipoproteinemia (a) and established cardiovascular disease. The aim of the trial is the clarify the dose level and frequency for a planned Phase 3 cardiovascular outcome study. Top-line data should be available in mid-2018.</li><li>AKCEO-APO(a)-Lrx, along with AKCEA-APOIII-Lrx, is part of Akcea's collaboration with Novartis. Both are antisense drugs to treat lipid disorders.</li><li>Lp(a) is a lipoprotein particle assembled in the liver that is associated with an increased risk of coronary heart disease. ApoC-III is a protein produced in the liver that plays a key role in the regulation of serum triglycerides.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3233823-ionis-subsidiary-akcea-collaborate-novartis-develop-two-cardiovascular-candidates-deal-valued\" target=\"_blank\">Ionis and subsidiary Akcea collaborate with Novartis to develop two cardiovascular candidates in deal valued as high as $1.7B; Ionis up 8% premarket</a> (Jan. 6)</li></ul><div class=\"tiny-share-widget\" data-id=\"3254515\" data-linked=\"Ionis Pharma&#39;s Akcea launches mid-stage study of dyslipidemia candidate to identify dosage regimen for late-stage cardiovascular outcomes study; shares ahead 3%\" data-tweet=\"$IONS - Ionis Pharma&#39;s Akcea launches mid-stage study of dyslipidemia candidate to identify dosage regimen for late-stage cardiovascular outcomes study; shares ahead 3% https://seekingalpha.com/news/3254515-ionis-pharmas-akcea-launches-mid-stage-study-of-dyslipidemia-candidate-to-identify-dosage?source=tweet\" data-url=\"https://seekingalpha.com/news/3254515-ionis-pharmas-akcea-launches-mid-stage-study-of-dyslipidemia-candidate-to-identify-dosage\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:44 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3254511\" data-ts=\"1490891404\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CMTL\" target=\"_blank\">CMTL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3254511-comtech-telecom-gets-follow-on-military-contract-for-6_6m\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Comtech Telecom gets follow-on military contract for $6.6M</a></h4><ul>   <li>Comtech Telecommunications (<a href=\"http://seekingalpha.com/symbol/CMTL\" target=\"_blank\">CMTL</a> <font color='green'>+1.7%</font>) has secured a <a href=\"https://seekingalpha.com/pr/16785818-comtech-telecommunications-corp-wins-6_6-million-follow-contract-high-power-satcom-twtas\" target=\"_blank\">follow-on contract for more than $6.6M</a> covering high-power satellite communication traveling wave tube amplifiers (TWTAs).</li>    <li>The deal came between Comtech's subsidiary Xicom (part of its Commercial Solutions segment) and a U.S. military integrator.</li>    <li>It's the third multi-year award for such power amplifiers.</li>    <li>Xicom makes a number of tube-based and solid-state amplifiers for satellite uplinks, including power levels from 8 W to 3 kW, in frequencies from 2 GHz to 45 GHz.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3254511\" data-linked=\"Comtech Telecom gets follow-on military contract for $6.6M\" data-tweet=\"$CMTL - Comtech Telecom gets follow-on military contract for $6.6M https://seekingalpha.com/news/3254511-comtech-telecom-gets-follow-on-military-contract-for-6_6m?source=tweet\" data-url=\"https://seekingalpha.com/news/3254511-comtech-telecom-gets-follow-on-military-contract-for-6_6m\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:30 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3254509\" data-ts=\"1490890874\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AA\" target=\"_blank\">AA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3254509-alcoaplus-3-on-rio-tinto-takeover-chatter\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Alcoa +3% on Rio Tinto takeover chatter</a></h4><ul>     <li>Alcoa (<a href='https://seekingalpha.com/symbol/AA' title='Alcoa Corporation'>AA</a> <font color='green'>+3.1%</font>) pops higher amid chatter that bankers are working with Rio Tinto (<a href='https://seekingalpha.com/symbol/RIO' title='Rio Tinto plc'>RIO</a> <font color='green'>+0.7%</font>) on a <a href=\"http://thefly.com/landingPageNews.php?id=2527523&amp;headline=AA;RIO-Alcoa-moves-higher-amid-takeover-speculation\" target=\"_blank\">potential takeover bid</a> for the company, according to TheFly.com.</li><li>There is no known basis for the rumor at present, and no specifics are available, but shares are up on heavier than normal volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3254509\" data-linked=\"Alcoa +3% on Rio Tinto takeover chatter\" data-tweet=\"$AA $AA $RIO - Alcoa +3% on Rio Tinto takeover chatter https://seekingalpha.com/news/3254509-alcoaplus-3-on-rio-tinto-takeover-chatter?source=tweet\" data-url=\"https://seekingalpha.com/news/3254509-alcoaplus-3-on-rio-tinto-takeover-chatter\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:21 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3254504\" data-ts=\"1490889776\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3254504-consumer-top-gainers-losers-of-12-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer - Top Gainers / Losers as of 12:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/XELB' title='Xcel Brands, Inc.'>XELB</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/ROX' title='Castle Brands Inc'>ROX</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/VUZI' title='Vuzix Corp'>VUZI</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/OBCI' title='Ocean Bio-Chem, Inc.'>OBCI</a> <font color='green'>+6%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/LULU' title='Lululemon Athletica Inc.'>LULU</a> <font color='red'>-23%</font>. <a href='https://seekingalpha.com/symbol/KBSF' title='KBS Fashion Group Limited'>KBSF</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/ZX' title='China Zenix Auto International'>ZX</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/TIS' title='Orchids Paper Products Company'>TIS</a> <font color='red'>-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3254504\" data-linked=\"Consumer - Top Gainers / Losers as of 12:00 pm\" data-tweet=\"$XELB $ROX $VUZI - Consumer - Top Gainers / Losers as of 12:00 pm https://seekingalpha.com/news/3254504-consumer-top-gainers-losers-of-12-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3254504-consumer-top-gainers-losers-of-12-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:02 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3254502\" data-ts=\"1490889314\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RF\" target=\"_blank\">RF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3254502-big-bounce-in-banks-to-end-month\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Big bounce in banks to end the month</a></h4><ul><li>The formerly red-hot banking sector had been&nbsp;<font color='red'>down 10%</font>&nbsp;this month, but today continues to bounce from the lows hit at the open on Monday.</li><li>The SPDR Regional Banking ETF (NYSEARCA:<a href='https://seekingalpha.com/symbol/KRE' title='SPDR S&P Regional Banking ETF'>KRE</a>) is&nbsp;<font color='green'>higher by 2.75%</font>&nbsp;this session and the SPDR KBW Bank ETF (NYSEARCA:<a href='https://seekingalpha.com/symbol/KBE' title='SPDR S&P Bank ETF'>KBE</a>)&nbsp;<font color='green'>up 2.4%</font>. This against an S&amp;P 500&nbsp;<font color='green'>up just 0.25%</font>.</li><li>Higher yields may be helping - the 10-year Treasury is up 2 basis points to 2.40%. Also a catalyst is the idea that the<a href=\"https://seekingalpha.com/news/3254176-bank-de-regulation-without-congress\" target=\"_blank\"> president doesn't need Congress</a> to push through large chunks of his eased regulatory agenda.</li><li>Regional players on the move include: Regions Financial (<a href='https://seekingalpha.com/symbol/RF' title='Regions Financial Corporation'>RF</a> <font color='green'>+2.4%</font>), Huntington Bancshares (<a href='https://seekingalpha.com/symbol/HBAN' title='Huntington Bancshares Incorporated'>HBAN</a> <font color='green'>+2%</font>), KeyCorp (<a href='https://seekingalpha.com/symbol/KEY' title='KeyCorp'>KEY</a> <font color='green'>+2.3%</font>), Fifth Third (<a href='https://seekingalpha.com/symbol/FITB' title='Fifth Third Bancorp'>FITB</a> <font color='green'>+2.7%</font>), Valley National (<a href='https://seekingalpha.com/symbol/VLY' title='Valley National Bancorp'>VLY</a> <font color='green'>+2.7%</font>), Zions (<a href='https://seekingalpha.com/symbol/ZION' title='Zions Bancorporation'>ZION</a> <font color='green'>+2.4%</font>), Comerica (<a href='https://seekingalpha.com/symbol/CMA' title='Comerica Inc.'>CMA</a> <font color='green'>+2.2%</font>), PNC Financial (<a href='https://seekingalpha.com/symbol/PNC' title='PNC Financial Services Group, Inc.'>PNC</a> <font color='green'>+1.5%</font>).</li></ul><div class=\"tiny-share-widget\" data-id=\"3254502\" data-linked=\"Big bounce in banks to end the month\" data-tweet=\"$RF $KRE $KBE - Big bounce in banks to end the month https://seekingalpha.com/news/3254502-big-bounce-in-banks-to-end-month?source=tweet\" data-url=\"https://seekingalpha.com/news/3254502-big-bounce-in-banks-to-end-month\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:55 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3254500\" data-ts=\"1490888531\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CVE\" target=\"_blank\">CVE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3254500-cenovus-energyminus-11-massive-deal-seen-increasing-debt-leverage\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cenovus Energy -11% as massive deal seen increasing debt, leverage</a></h4><ul>     <li>Cenovus Energy (<a href='https://seekingalpha.com/symbol/CVE' title='Cenovus Energy, Inc.'>CVE</a> <font color='red'>-11.5%</font>) slumps to 52-week lows following its <a href=\"https://seekingalpha.com/news/3254276-cenovus-buy-conocophillips-50-percent-stake-fccl-assets-c-17_7b\" target=\"_blank\">purchase</a> of ConocoPhillips&rsquo; (<a href='https://seekingalpha.com/symbol/COP' title='ConocoPhillips'>COP</a> <font color='green'>+8.7%</font>) Canadian assets catapults, which catapults the company into the top three in the oil sands but the amount of debt it is taking on is raising red flags.</li><li>CEO Brian Ferguson called the deal &ldquo;a unique  opportunity to take full control of our oil sands assets,&rdquo; during a  conference call, adding that it would <a href=\"http://business.financialpost.com/news/energy/cenovus-to-buy-conocophillips-canadian-assets-for-a-massive-17-7-billion\" target=\"_blank\">double CVE&rsquo;s total  production and reserves</a>; he also said CVE plans to sell off its Pelican Lake oil sands properties and some light oil assets in Alberta as a result of the deal, and the company would revisit its dividend once those assets sold.</li><li>But analysts say the deal will weigh on shares in the near-term</a>; Raymond James' Chris Cox says CVE takes on a &ldquo;noticeably higher risk profile&rdquo; after the deal, and investors are unlikely to see any appeal in the decision to deploy capital towards acquisitions rather than buybacks.</li><li>Morgan Stanley's Benny Wong says the deal simplifies CVE's operating structure and decision making, and buying producing assets that are familiar and top-tier is a &ldquo;much  more welcome scenario for the market rather than accelerating spend to  develop new projects and have to wait several years before seeing cash  flow.&rdquo;</li><li>Canaccord's Dennis Fong says the price paid for the assets is fair, but the diversification from oil sands may confuse investors, yet he sees a sound strategic  basis in acquiring assets which can aid in showing short-cycle growth and provide a source for natural gas liquids.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3254500\" data-linked=\"Cenovus Energy -11% as massive deal seen increasing debt, leverage\" data-tweet=\"$CVE $CVE $COP - Cenovus Energy -11% as massive deal seen increasing debt, leverage https://seekingalpha.com/news/3254500-cenovus-energyminus-11-massive-deal-seen-increasing-debt-leverage?source=tweet\" data-url=\"https://seekingalpha.com/news/3254500-cenovus-energyminus-11-massive-deal-seen-increasing-debt-leverage\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:42 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3254498\" data-ts=\"1490888173\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VEON\" target=\"_blank\">VEON</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3254498-vimpelcom-shareholders-approve-rebranding-to-veon\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">VimpelCom shareholders approve rebranding to VEON</a></h4><ul>   <li>VimpelCom (<a href=\"http://seekingalpha.com/symbol/VIP\" target=\"_blank\">VIP</a> <font color='green'>+2%</font>) has <a href=\"https://seekingalpha.com/pr/16785870-shareholders-approve-renaming-veon\" target=\"_blank\">gotten shareholder approval</a> for its <a href=\"https://seekingalpha.com/news/3246743-vimpelcom-becoming-veon-minus-1_6-percent-revenue-miss\" target=\"_blank\">name change to VEON</a>.</li>    <li>The company set the change to signal its transition from strictly mobile telecom to more general global technology.</li>    <li>It's also amending by-laws to \"improve the efficiency of decision-making\" while ensuring there's still satisfactory Supervisory Board oversight, it says.</li>    <li>With approval secured at today's special meeting, the company will trade on Nasdaq as <a href='https://seekingalpha.com/symbol/VEON' title='VEON Ltd. ADS'>VEON</a> starting tomorrow.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3254498\" data-linked=\"VimpelCom shareholders approve rebranding to VEON\" data-tweet=\"$VEON - VimpelCom shareholders approve rebranding to VEON https://seekingalpha.com/news/3254498-vimpelcom-shareholders-approve-rebranding-to-veon?source=tweet\" data-url=\"https://seekingalpha.com/news/3254498-vimpelcom-shareholders-approve-rebranding-to-veon\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:36 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3254496\" data-ts=\"1490888012\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CM\" target=\"_blank\">CM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3254496-cibc-boosts-bid-for-privatebancorp-shares-climb-6\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CIBC boosts bid for PrivateBancorp; shares climb 6%</a></h4><ul><li><a href=\"https://seekingalpha.com/pr/16785741-cibc-privatebancorp-announce-revised-merger-agreement\" target=\"_blank\">The deal would now be</a> for $24.20 in cash and 0.4176 shares of CIBC (<a href='https://seekingalpha.com/symbol/CM' title='Canadian Imperial Bank of Commerce'>CM</a> <font color='red'>-1.7%</font>) for each share of PrivateBancorp (<a href='https://seekingalpha.com/symbol/PVTB' title='PrivateBancorp, Inc.'>PVTB</a> <font color='green'>+5.8%</font>). Based on yesterday's close, it values PVTB at $4.9B, or $60.92 per share - 20% higher than the initial terms from last summer, and valuing the company at 2.7x tangible book value.</li><li>The deal is hoped to close in Q2.</li><li>Not enough, says KBW's Chris McGratty. He says PVTB is worth $70.</li><li>Barclays' John Aiken says the new offer is plenty, and that CIBC owners probably won't like it.</li><li>PVTB's gain today puts the stock at $59.47.</li></ul><div class=\"tiny-share-widget\" data-id=\"3254496\" data-linked=\"CIBC boosts bid for PrivateBancorp; shares climb 6%\" data-tweet=\"$CM $CM $PVTB - CIBC boosts bid for PrivateBancorp; shares climb 6% https://seekingalpha.com/news/3254496-cibc-boosts-bid-for-privatebancorp-shares-climb-6?source=tweet\" data-url=\"https://seekingalpha.com/news/3254496-cibc-boosts-bid-for-privatebancorp-shares-climb-6\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:33 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3254484\" data-ts=\"1490886853\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PRAN\" target=\"_blank\">PRAN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3254484-prana-bios-parkinsons-candidate-pbt434-shows-encouraging-action-in-preclinical-testing-shares\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Prana Bio&#39;s Parkinson&#39;s candidate PBT434 shows encouraging action in preclinical testing; shares jump 43%</a></h4><ul><li>Ultra-thinly traded nano cap Prana Biotechnology (<a href='https://seekingalpha.com/symbol/PRAN' title='Prana Biotechnology Ltd'>PRAN</a> <font color='green'>+42.7%</font>) rockets on a whopping 427x surge in volume in response to its <a href=\"https://seekingalpha.com/filing/3480083\" target=\"_blank\">announcement </a>of positive preclinical on Parkinson's disease candidate PBT434. The results are being presented at the 13th International Conference for Alzheimer's and Parkinson's Diseases in Vienna, Austria.</li><li>The poster presents<em> in vivo</em> evidence of the ability of PBT434 to prevent the loss of neurons that cause motor and cognitive dysfunction by preventing the degenerative processes that lead to neuron cell death.</li><li>PBT434 lowers the accumulation of a key protein called alpha-synuclein, which damages the nerve cells of the substantia nigra part of the part of the brain where movement is controlled.</li></ul><div class=\"tiny-share-widget\" data-id=\"3254484\" data-linked=\"Prana Bio&#39;s Parkinson&#39;s candidate PBT434 shows encouraging action in preclinical testing; shares jump 43%\" data-tweet=\"$PRAN $ATHE - Prana Bio&#39;s Parkinson&#39;s candidate PBT434 shows encouraging action in preclinical testing; shares jump 43% https://seekingalpha.com/news/3254484-prana-bios-parkinsons-candidate-pbt434-shows-encouraging-action-in-preclinical-testing-shares?source=tweet\" data-url=\"https://seekingalpha.com/news/3254484-prana-bios-parkinsons-candidate-pbt434-shows-encouraging-action-in-preclinical-testing-shares\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:14 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3254490\" data-ts=\"1490886683\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FSRL\" target=\"_blank\">FSRL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3254490-first-solar-completes-sale-of-250-mw-nevada-power-plant\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">First Solar completes sale of 250 MW Nevada power plant</a></h4><ul>     <li>First Solar (<a href='https://seekingalpha.com/symbol/FSRL' title='First Reliance Bancshares, Inc.'>OTCPK:FSRL</a>) says it <a href=\"https://seekingalpha.com/pr/16785381-first-solar-sells-moapa-solar-project-capital-dynamics\" target=\"_blank\">completed the sale</a> of the 250 MW Moapa Southern Paiute solar power plant in Nevada to a unit of Swiss asset manager Capital Dynamics for an unspecified sum.</li>     <li>Minority tax equity interests in the project are shared by GE Energy Financial Services and a Goldman Sachs affiliate.</li>     <li>FSLR says it will continue to operate and maintain the power plant, which has a 25-year power purchase agreement with the Los Angeles Department of Water &amp; Power.</li></ul><div class=\"tiny-share-widget\" data-id=\"3254490\" data-linked=\"First Solar completes sale of 250 MW Nevada power plant\" data-tweet=\"$FSRL - First Solar completes sale of 250 MW Nevada power plant https://seekingalpha.com/news/3254490-first-solar-completes-sale-of-250-mw-nevada-power-plant?source=tweet\" data-url=\"https://seekingalpha.com/news/3254490-first-solar-completes-sale-of-250-mw-nevada-power-plant\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:11 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3254486\" data-ts=\"1490885897\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FCX\" target=\"_blank\">FCX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3254486-freeport-mcmoran-may-be-nearing-export-deal-indonesia-sharesplus-5\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Freeport McMoRan may be nearing export deal with Indonesia; shares +5%</a></h4><ul><li>Freeport McMoRan (<a href='https://seekingalpha.com/symbol/FCX' title='Freeport-McMoRan Inc.'>FCX</a> <font color='green'>+5.5%</font>) is <a href=\"http://www.reuters.com/article/indonesia-freeport-idUSL3N1H740D\" target=\"_blank\">close to reaching a deal</a> that  would allow it to temporarily resume copper concentrate  exports from its Grasberg mine, Indonesia's mining minister  says.</li><li>FCX would be allowed to resume exports for the next six months  while continuing to negotiate fiscal terms for the new permit, the minister says, adding that the discussions would be handled by Indonesia's  finance ministry and would focus on its request for a \"nailed down\" tax  rate and guarantees that other fiscal terms would not change.</li><li>The government halted FCX's concentrate exports in mid January in an  attempt to improve revenues from mining resources and create jobs, but the change in tone could signal that the 10-week stoppage of exports from the world's second-biggest copper mine is near an end.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/JJC' title='iPath Series B Bloomberg Copper Subindex Total Return ETN'>JJC</a>, <a href='https://seekingalpha.com/symbol/CPER' title='United States Copper Index ETF'>CPER</a>, <a href='https://seekingalpha.com/symbol/CUPM' title='iPath Pure Beta Copper ETN'>CUPM</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3254486\" data-linked=\"Freeport McMoRan may be nearing export deal with Indonesia; shares +5%\" data-tweet=\"$FCX $FCX $JJCTF - Freeport McMoRan may be nearing export deal with Indonesia; shares +5% https://seekingalpha.com/news/3254486-freeport-mcmoran-may-be-nearing-export-deal-indonesia-sharesplus-5?source=tweet\" data-url=\"https://seekingalpha.com/news/3254486-freeport-mcmoran-may-be-nearing-export-deal-indonesia-sharesplus-5\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:58 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>41&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3254485\" data-ts=\"1490885406\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ROX\" target=\"_blank\">ROX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3254485-castle-brandsplus-95-ytd-on-ginger-beer-buzz\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Castle Brands +95% YTD on ginger beer buzz</a></h4><ul>          <li>Castle Brands (<a href='https://seekingalpha.com/symbol/ROX' title='Castle Brands Inc'>ROX</a> <font color='green'>+10.3%</font>) announces that it acquired an additional 20.1% stake in Gosling-Castle Partners Inc.</li>     <li>GCP holds the exclusive long-term export and distribution rights for Goslings Rum and Goslings Stormy Ginger Beer for all countries other than Bermuda.</li>     <li>The transaction increases Castle Brands ownership of GCP to 80.1%.</li>     <li>\"We believe that our sales and marketing initiatives will enhance Goslings Rum sales and that the strong growth of Goslings Stormy Ginger Beer will expand the consumer base, grow brand awareness and drive more consumer pull,\" says&nbsp;Castle Brands COO&nbsp;John Glover.</li><li>Shares of Castle Brands are now up 95% YTD as the company's new distribution deal with Wal-Mart continues to create a buzz.</li>     <li>Source: <a href=\"https://seekingalpha.com/pr/16785785-castle-brands-announces-key-new-developments-goslings\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3254485\" data-linked=\"Castle Brands +95% YTD on ginger beer buzz\" data-tweet=\"$ROX - Castle Brands +95% YTD on ginger beer buzz https://seekingalpha.com/news/3254485-castle-brandsplus-95-ytd-on-ginger-beer-buzz?source=tweet\" data-url=\"https://seekingalpha.com/news/3254485-castle-brandsplus-95-ytd-on-ginger-beer-buzz\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:50 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3254481\" data-ts=\"1490884808\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JILL\" target=\"_blank\">JILL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3254481-post-ipo-high-for-j-jill-group\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Post-IPO high for J. Jill Group</a></h4><ul> <li>J. Jill Group (<a href='https://seekingalpha.com/symbol/JILL' title='J. Jill Group, Inc.'>JILL</a> <font color='green'>+2.3%</font>) impresses with a 10.8% increase in comparable store sales during Q4 and guidance for a high single digit comp for Q1.</li> <li>The retailer, which has a thriving e-commerce business, saw direct to consumer sales increase to 48.8% of total sales vs. 46.1% last year.</li> <li>Adjusted EBITDA was up 46% Y/Y to $22.5M in Q4.</li> <li>J. Jill jumped to a post-IPO high of $13.71 today. Wall Street firms are still quiet on the stock, but several Seeking Alpha contributors have <a href=\"https://seekingalpha.com/symbol/JILL/focus\" target=\"_blank\">articles</a> dissecting the upside potential.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3254481\" data-linked=\"Post-IPO high for J. Jill Group\" data-tweet=\"$JILL - Post-IPO high for J. Jill Group https://seekingalpha.com/news/3254481-post-ipo-high-for-j-jill-group?source=tweet\" data-url=\"https://seekingalpha.com/news/3254481-post-ipo-high-for-j-jill-group\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:40 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3254480\" data-ts=\"1490884691\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WINS\" target=\"_blank\">WINS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3254480-40-bagger-wins-finance-slips-16-analysts-look\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">40-bagger Wins Finance slips 16% as analysts have a look</a></h4><ul><li>At one point earlier this year, shares of the company - a small-business loan and leasing company in China - were up more than 4,000% since debuting on the Nasdaq late in 2015.</li><li>At the peak, Wins' (<a href='https://seekingalpha.com/symbol/WINS' title='Wins Finance Holdings Inc.'>WINS</a> <font color='red'>-16.1%</font>) market cap was $9B, or four times that of Lending Club, a lender with 50x the revenue.</li><li>What gives? Bloomberg <a href=\"https://www.bloomberg.com/news/articles/2017-03-30/this-chinese-stock-soared-4-500-on-nasdaq-and-no-one-knows-why\" target=\"_blank\">takes a look today</a>, as does <a href=\"https://seekingalpha.com/article/4059103-wins-finance-active-sec-investigation-manipulation-russell-index\" target=\"_blank\">Seeking Alpha contributor Fuzzy Panda Shorts</a>, who calls the \"highly manipulated\" stock a zero.</li></ul><div class=\"tiny-share-widget\" data-id=\"3254480\" data-linked=\"40-bagger Wins Finance slips 16% as analysts have a look\" data-tweet=\"$WINS - 40-bagger Wins Finance slips 16% as analysts have a look https://seekingalpha.com/news/3254480-40-bagger-wins-finance-slips-16-analysts-look?source=tweet\" data-url=\"https://seekingalpha.com/news/3254480-40-bagger-wins-finance-slips-16-analysts-look\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:38 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>26&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3254478\" data-ts=\"1490884237\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3254478-natural-gas-inventory-draw-par-consensus\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Natural gas inventory draw at par with consensus</a></h4><ul>     <li><a href=\"http://ir.eia.gov/ngs/ngs.html\" target=\"_blank\">EIA Natural Gas Inventory:</a> <strong>-43</strong> <strong>Bcf </strong>vs. -42 Bcf consensus, -150 Bcf last week.</li><li>Futures&nbsp;<font color='red'>-1.21%</font>&nbsp;to $3.192.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/UNG' title='The United States Natural Gas ETF, LP'>UNG</a>, <a href='https://seekingalpha.com/symbol/DGAZ' title='VelocityShares 3x Inverse Natural Gas ETN'>DGAZ</a>, <a href='https://seekingalpha.com/symbol/UGAZ' title='VelocityShares 3x Long Natural Gas ETN'>UGAZ</a>, <a href='https://seekingalpha.com/symbol/BOIL' title='ProShares Ultra Bloomberg Natural Gas ETF'>BOIL</a>, <a href='https://seekingalpha.com/symbol/GAZ' title='iPath DJ-UBS Natural Gas Total Return Sub-Index ETN'>GAZ</a>, <a href='https://seekingalpha.com/symbol/KOLD' title='ProShares UltraShort Bloomberg Natural Gas ETF'>KOLD</a>, <a href='https://seekingalpha.com/symbol/UNL' title='The United States 12 Month Natural Gas ETF, LP'>UNL</a>, <a href='https://seekingalpha.com/symbol/DCNG' title='iPath Pure Beta Seasonal Natural Gas ETN'>DCNG</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3254478\" data-linked=\"Natural gas inventory draw at par with consensus\" data-tweet=\"$UNG $DGAZ $UGAZ - Natural gas inventory draw at par with consensus https://seekingalpha.com/news/3254478-natural-gas-inventory-draw-par-consensus?source=tweet\" data-url=\"https://seekingalpha.com/news/3254478-natural-gas-inventory-draw-par-consensus\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:30 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>30&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3254475\" data-ts=\"1490883867\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/COP\" target=\"_blank\">COP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3254475-conocophillipsplus-6_5-divestiture-seen-big-win-for-shareholders\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ConocoPhillips +6.5% as divestiture seen as big win for shareholders</a></h4><ul><li>ConocoPhillips (<a href='https://seekingalpha.com/symbol/COP' title='ConocoPhillips'>COP</a> <font color='green'>+6.4%</font>) is the top gainer on the S&amp;P 500 in early trading amid widespread praise for the <a href=\"https://seekingalpha.com/news/3254276-cenovus-buy-conocophillips-50-percent-stake-fccl-assets-c-17_7b\" target=\"_blank\">sale of its 50% interest</a> in the FCCL partnership with Cenovus Energy (<a href='https://seekingalpha.com/symbol/CVE' title='Cenovus Energy, Inc.'>CVE</a> <font color='red'>-10.6%</font>), as it allows for debt reduction and share buybacks.</li><li>Cowen analyst Charles Robertson says some investors were  skeptical of COP's plan announced in November to sell $3B-$5B in assets and buy back $3B worth of  stock, but the \"<a href=\"http://www.marketwatch.com/story/conocophillips-stock-surges-as-investors-analysts-cheer-unexpected-big-deal-2017-03-30\" target=\"_blank\">unexpected big deal</a>\" with CVE accomplished the plan in less than  a year.</li><li>UBS <a href=\"https://www.streetinsider.com/Analyst+Comments/UBS+Upgrades+ConocoPhillips+%28COP%29+to+Buy/12721952.html\" target=\"_blank\">upgrades shares to Buy</a> from Neutral with a $55 price target, up from $51, saying COP is divesting a &ldquo;low growth, low margin asset that will enable it to immediately reduce its debt load by ~$7B,\" and the deal improves COP&rsquo;s production mix with lower margin bitumen  dropping to 5% from 15% as higher margin oil increases to 40% from 35%.</li><li>Evercore ISI says the deal creates &ldquo;significant value,\" and appears accretive to return on equity, earnings and cash margins; analyst Doug Terreson says COP management is leading Big Oil and the E&amp;P industry on positive, shareholder oriented change.</li></ul><div class=\"tiny-share-widget\" data-id=\"3254475\" data-linked=\"ConocoPhillips +6.5% as divestiture seen as big win for shareholders\" data-tweet=\"$COP $COP $CVE - ConocoPhillips +6.5% as divestiture seen as big win for shareholders https://seekingalpha.com/news/3254475-conocophillipsplus-6_5-divestiture-seen-big-win-for-shareholders?source=tweet\" data-url=\"https://seekingalpha.com/news/3254475-conocophillipsplus-6_5-divestiture-seen-big-win-for-shareholders\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:24 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>37&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3254473\" data-ts=\"1490883502\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BGCP\" target=\"_blank\">BGCP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3254473-bgc-partnersplus-1_7-after-optimistic-outlook\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BGC Partners +1.7% after optimistic outlook</a></h4><ul><li>The <a href=\"https://seekingalpha.com/pr/16785219-bgc-partners-updates-outlook-first-quarter-2017\" target=\"_blank\">company expects both</a> revenues and pre-tax distributable earnings for Q1 to come in near the high-end of previous guidance.</li><li>Full results are due on May 4.</li><li><a href='https://seekingalpha.com/symbol/BGCP' title='BGC Partners, Inc.'>BGCP</a>&nbsp;<font color='green'>+1.7%</font></li></ul><div class=\"tiny-share-widget\" data-id=\"3254473\" data-linked=\"BGC Partners +1.7% after optimistic outlook\" data-tweet=\"$BGCP - BGC Partners +1.7% after optimistic outlook https://seekingalpha.com/news/3254473-bgc-partnersplus-1_7-after-optimistic-outlook?source=tweet\" data-url=\"https://seekingalpha.com/news/3254473-bgc-partnersplus-1_7-after-optimistic-outlook\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:18 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3254467\" data-ts=\"1490882552\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OFS\" target=\"_blank\">OFS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3254467-ofs-capital-down-nearly-6-after-raising-equity\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">OFS Capital down nearly 6% after raising equity</a></h4><ul><li>OFS Capital (<a href='https://seekingalpha.com/symbol/OFS' title='OFS Capital'>OFS</a> <font color='red'>-5.9%</font>) priced <a href=\"https://seekingalpha.com/pr/16785719-ofs-capital-corporation-announces-pricing-3500-000-shares-common-stock\" target=\"_blank\">a 3.5M share sale at</a> $14.57 each. December 31 NAV per share was $14.82.</li><li>The external adviser has agreed to pay the underwriting fee and the $0.25 difference between the offering price and book value, so OFS will see net proceeds of $14.82 per share.</li></ul><div class=\"tiny-share-widget\" data-id=\"3254467\" data-linked=\"OFS Capital down nearly 6% after raising equity\" data-tweet=\"$OFS - OFS Capital down nearly 6% after raising equity https://seekingalpha.com/news/3254467-ofs-capital-down-nearly-6-after-raising-equity?source=tweet\" data-url=\"https://seekingalpha.com/news/3254467-ofs-capital-down-nearly-6-after-raising-equity\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:02 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3254464\" data-ts=\"1490882343\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PFMT\" target=\"_blank\">PFMT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3254464-performant-financial-jumps-after-favorable-gao-ruling\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Performant Financial jumps after favorable GAO ruling</a></h4><ul> <li>Performant Financial (<a href='https://seekingalpha.com/symbol/PFMT' title='Performant Financial'>PFMT</a> <font color='green'>+14.1%</font>) rallies after the company confirms that the General Accounting Office upheld its protest of Department of Education collection decision.</li> <li>A formal written decision is expected within a few days.</li> <li><a href=\"https://seekingalpha.com/filing/3479651\" target=\"_blank\">SEC Form 8-K</a></li>  </ul><div class=\"tiny-share-widget\" data-id=\"3254464\" data-linked=\"Performant Financial jumps after favorable GAO ruling\" data-tweet=\"$PFMT - Performant Financial jumps after favorable GAO ruling https://seekingalpha.com/news/3254464-performant-financial-jumps-after-favorable-gao-ruling?source=tweet\" data-url=\"https://seekingalpha.com/news/3254464-performant-financial-jumps-after-favorable-gao-ruling\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:59 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3254461\" data-ts=\"1490882107\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CF\" target=\"_blank\">CF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3254461-cf-industriesminus-3-cleveland-research-sees-weak-urea-pricing\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CF Industries -3% as Cleveland Research sees weak urea pricing</a></h4><ul><li>CF&nbsp;Industries (<a href='https://seekingalpha.com/symbol/CF' title='CF Industries Holdings, Inc.'>CF</a> <font color='red'>-2.8%</font>) opens lower after Cleveland Research <a href=\"https://twitter.com/thenotablecalls/status/847441208318148611\" target=\"_blank\">turns sharply negative</a> on the shares, as the firm forecasts weakening urea pricing.</li><li>Cleveland says it is <a href=\"https://twitter.com/thenotablecalls/status/847441242673643520\" target=\"_blank\">even more cautious on H2</a> 2017 than H1 due to the impact of new capacity additions coming later this year.</li><li>The firm sees potential near-term <a href=\"https://twitter.com/thenotablecalls/status/847441228207607809\" target=\"_blank\">downside to $25</a> for the stock, as it lowers its 2017 EPS outlook to a $0.29 loss vs. Wall Street consensus of $0.63 earnings.</li></ul><div class=\"tiny-share-widget\" data-id=\"3254461\" data-linked=\"CF Industries -3% as Cleveland Research sees weak urea pricing\" data-tweet=\"$CF - CF Industries -3% as Cleveland Research sees weak urea pricing https://seekingalpha.com/news/3254461-cf-industriesminus-3-cleveland-research-sees-weak-urea-pricing?source=tweet\" data-url=\"https://seekingalpha.com/news/3254461-cf-industriesminus-3-cleveland-research-sees-weak-urea-pricing\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:55 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>17&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3254456\" data-ts=\"1490881617\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ACST\" target=\"_blank\">ACST</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3254456-acasti-pharma-to-proceed-late-stage-development-of-capre-for-treatment-of-high-triglycerides\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Acasti Pharma to proceed with late-stage development of CaPre for the treatment of high triglycerides; shares ahead 7%</a></h4><ul><li>Thinly traded nano cap Acasti Pharma (<a href='https://seekingalpha.com/symbol/ACST' title='Acasti Pharma, Inc.'>ACST</a> <font color='green'>+7.1%</font>) is up in early trading, albeit on less than 20K shares, in response to its <a href=\"https://seekingalpha.com/pr/16785457-acasti-pharma-provides-update-capre-phase-3-development-program\" target=\"_blank\">announcement </a>that it intends to advance lead product candidate CaPre (omega-3 phospholipid) into Phase 3 development for the treatment of patients with hypertriglyceridemia.</li><li>The company will conduct two pivotal studies in patients with very high blood triglycerides (at least 500 mg/dL). If all goes well, it will file its U.S. marketing application under the abbreviated 505(b)(2) pathway.</li><li><a href=\"http://www.acastipharma.com/capre/\" target=\"_blank\">CaPre</a>&nbsp;is a highly concentrated omega-3 phospholipid, principally EPA and DHA, derived from krill. Acasti says it is absorbed more readily into the body than GlaxoSmithKline's (<a href='https://seekingalpha.com/symbol/GSK' title='GlaxoSmithKline'>GSK</a> <font color='red'>-0.3%</font>) LOVAZA (omega-3-acid ethyl esters) because the EPA and DHA are naturally free or bound to phospholipids instead of being \"esterified.\"</li></ul><div class=\"tiny-share-widget\" data-id=\"3254456\" data-linked=\"Acasti Pharma to proceed with late-stage development of CaPre for the treatment of high triglycerides; shares ahead 7%\" data-tweet=\"$ACST $ACST $GSK - Acasti Pharma to proceed with late-stage development of CaPre for the treatment of high triglycerides; shares ahead 7% https://seekingalpha.com/news/3254456-acasti-pharma-to-proceed-late-stage-development-of-capre-for-treatment-of-high-triglycerides?source=tweet\" data-url=\"https://seekingalpha.com/news/3254456-acasti-pharma-to-proceed-late-stage-development-of-capre-for-treatment-of-high-triglycerides\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:46 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3254453\" data-ts=\"1490881005\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3254453-trump-looking-for-new-ways-to-go-after-currency-manipulators-cnbc\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Trump looking for new ways to go after currency manipulators - CNBC</a></h4><ul><li>The yen strengthens on the above-headline <a href=\"https://twitter.com/CNBC/status/847436613269336065\" target=\"_blank\">reported minutes ago</a> at CNBC. Presumably, the president has China's yuan in mind as well.</li><li>Down earlier in the session, the yen has returned to flat vs. the dollar.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/FXY' title='CurrencyShares Japanese Yen Trust ETF'>FXY</a>, <a href='https://seekingalpha.com/symbol/YCS' title='ProShares UltraShort Yen ETF'>YCS</a>, <a href='https://seekingalpha.com/symbol/CYB' title='WisdomTree Chinese Yuan ETF'>CYB</a>, <a href='https://seekingalpha.com/symbol/CNY' title='Market Vectors Chinese Renminbi/USD ETN'>CNY</a>, <a href='https://seekingalpha.com/symbol/JYN' title='iPath JPY/USD Exchange Rate ETN'>JYN</a>, <a href='https://seekingalpha.com/symbol/FXCH' title='CurrencyShares Chinese Renminbi Trust ETF'>FXCH</a>, <a href='https://seekingalpha.com/symbol/YCL' title='ProShares Ultra Yen ETF'>YCL</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3254453\" data-linked=\"Trump looking for new ways to go after currency manipulators - CNBC\" data-tweet=\"$FXY $YCS $CYB - Trump looking for new ways to go after currency manipulators - CNBC https://seekingalpha.com/news/3254453-trump-looking-for-new-ways-to-go-after-currency-manipulators-cnbc?source=tweet\" data-url=\"https://seekingalpha.com/news/3254453-trump-looking-for-new-ways-to-go-after-currency-manipulators-cnbc\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:36 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3254450\" data-ts=\"1490880631\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AKER\" target=\"_blank\">AKER</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3254450-akers-biosciences-reports-fy16-preliminary-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Akers Biosciences reports FY16 preliminary results</a></h4><ul><li>Akers Biosciences (<a href='https://seekingalpha.com/symbol/AKER' title='Akers Biosciences Inc.'>AKER</a>) <a href=\"https://seekingalpha.com/pr/16785555-akers-biosciences-reports-preliminary-unaudited-earnings-highlights-fiscal-year-2016\" target=\"_blank\">FY16 results</a>: Total revenue: $2.96M (+40% Y/Y).</li><li>Gross income: $1.88M.</li><li>Cash and marketable securities: $0.12M.</li><li>Shares are up&nbsp;<font color='green'>8%</font>&nbsp;premarket.</li></ul><div class=\"tiny-share-widget\" data-id=\"3254450\" data-linked=\"Akers Biosciences reports FY16 preliminary results\" data-tweet=\"$AKER - Akers Biosciences reports FY16 preliminary results https://seekingalpha.com/news/3254450-akers-biosciences-reports-fy16-preliminary-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3254450-akers-biosciences-reports-fy16-preliminary-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:30 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3254449\" data-ts=\"1490880571\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LKM\" target=\"_blank\">LKM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3254449-nq-mobileplus-9_7-on-deals-to-divest-fl-mobile-sell-showself-business\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NQ Mobile +9.7% on deals to divest FL Mobile, sell Showself business</a></h4><ul>   <li>NQ Mobile (NQ) is <font color='green'>up 9.7%</font> premarket after word that it's set definitive deals to <a href=\"https://seekingalpha.com/pr/16785485-nq-mobile-inc-enters-definitive-agreements-complete-fl-mobile-divestment-sale-showselfs-live\" target=\"_blank\">complete its FL Mobile divestment</a> and to sell Showself's live social video business.</li>    <li>Tongfang Investment Fund Series SPC will take 63% equity interest in FL Mobile Juitian for 2.52B yuan (about $366M), which values FL Mobile at 4B yuan (about $580.5M). It will also take 65% in Beijing Showself's business for 800M yuan ($116.1M), which values that entire business at 1.23B yuan ($178.5M).</li>    <li>Tongfang will pay 150M yuan in cash as earnest money, with the rest coming by May 31.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3254449\" data-linked=\"NQ Mobile +9.7% on deals to divest FL Mobile, sell Showself business\" data-tweet=\"$LKM - NQ Mobile +9.7% on deals to divest FL Mobile, sell Showself business https://seekingalpha.com/news/3254449-nq-mobileplus-9_7-on-deals-to-divest-fl-mobile-sell-showself-business?source=tweet\" data-url=\"https://seekingalpha.com/news/3254449-nq-mobileplus-9_7-on-deals-to-divest-fl-mobile-sell-showself-business\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:29 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3254445\" data-ts=\"1490880338\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PGNX\" target=\"_blank\">PGNX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3254445-progenics-pharmas-azedra-successful-in-mid-stage-study-in-rare-tumors-shares-slump-7\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Progenics Pharma&#39;s Azedra successful in mid-stage study in rare tumors; shares slump 7% premarket on cloudy nature of data reporting</a></h4><ul><li>Usually positive trial data gooses stock prices, but not Progenics Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/PGNX' title='Progenics Pharmaceuticals Inc.'>PGNX</a>). Shares are down&nbsp;<font color='red'>7%</font>&nbsp;premarket on increased volume in response to its <a href=\"https://seekingalpha.com/pr/16785234-progenics-pharmaceuticals-announces-positive-topline-results-registrational-phase-2b-trial\" target=\"_blank\">announcement </a>of positive results from a <a href=\"https://clinicaltrials.gov/ct2/show/NCT00874614?term=azedra&amp;rank=3\" target=\"_blank\">Phase 2b study</a> assessing Breakthrough Therapy-, Orphan Drug- and Fast Track-tagged AZEDRA (iobenguane I 131) Injection in patients with rare neuroendocrine tumors called pheochromocytoma and paraganglioma.</li><li>The company says the trial met its primary endpoint of the proportion of participants who achieved at least a 50% reduction in all antihypertensive medication for at least six months. Usually the results are reported as \"statistically significant\" with a p value no greater than 0.05, but in this case it was reported in terms of the 95% confidence interval &#40;CI&#41;, specifically if the lower limit of the two-sided 95% CI was above 10%. The lower limit was 16.15% so it says the study met the primary endpoint per the protocol. The upper limit was 36.52%.</li><li>Progenics adds that 92.2% of patients who received at least one therapeutic dose of AZEDRA achieved a partial response or stable disease per RECIST criteria.</li><li>Additional data will be submitted for presentation at a future medical meeting. Management says it will complete its NDA filing by mid-year.</li></ul><div class=\"tiny-share-widget\" data-id=\"3254445\" data-linked=\"Progenics Pharma&#39;s Azedra successful in mid-stage study in rare tumors; shares slump 7% premarket on cloudy nature of data reporting\" data-tweet=\"$PGNX - Progenics Pharma&#39;s Azedra successful in mid-stage study in rare tumors; shares slump 7% premarket on cloudy nature of data reporting https://seekingalpha.com/news/3254445-progenics-pharmas-azedra-successful-in-mid-stage-study-in-rare-tumors-shares-slump-7?source=tweet\" data-url=\"https://seekingalpha.com/news/3254445-progenics-pharmas-azedra-successful-in-mid-stage-study-in-rare-tumors-shares-slump-7\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:25 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3254436\" data-ts=\"1490879855\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3254436-premarket-losers-of-9-05\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Losers as of 9:05 am</a></h4><ul>     <li><a href='https://seekingalpha.com/symbol/GEVO' title='Gevo, Inc.'>GEVO</a> <font color='red'>-21%</font>&nbsp;on Q4 earnings.</li><li><a href='https://seekingalpha.com/symbol/LULU' title='Lululemon Athletica Inc.'>LULU</a> <font color='red'>-21%</font>&nbsp;on weak 2017 guidance.</li><li><a href='https://seekingalpha.com/symbol/TNXP' title='Tonix Pharmaceuticals Holding Corp.'>TNXP</a> <font color='red'>-14%</font>&nbsp;on equity offering.</li><li><a href='https://seekingalpha.com/symbol/CRBP' title='Corbus Pharmaceuticals Holdings, Inc.'>CRBP</a> <font color='red'>-11%</font>&nbsp;on announcement of results from Phase 2 Clinical trial of anabasum in CF.</li><li><a href='https://seekingalpha.com/symbol/HALO' title='Halozyme Therapeutics, Inc.'>HALO</a> <font color='red'>-11%</font>&nbsp;on announcement of Phase 1b/2 clinical trial assessing PEGPH20.</li><li><a href='https://seekingalpha.com/symbol/CVE' title='Cenovus Energy, Inc.'>CVE</a> <font color='red'>-8%</font>&nbsp;on buying 50% interest in the Foster Creek Christina Lake partnership from ConocoPhillips.</li><li><a href='https://seekingalpha.com/symbol/PGNX' title='Progenics Pharmaceuticals Inc.'>PGNX</a> <font color='red'>-7%</font>.</li><li><a href='https://seekingalpha.com/symbol/OFS' title='OFS Capital'>OFS</a> <font color='red'>-5%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3254436\" data-linked=\"Premarket Losers as of 9:05 am\" data-tweet=\"$GEVO $LULU $TNXP - Premarket Losers as of 9:05 am https://seekingalpha.com/news/3254436-premarket-losers-of-9-05?source=tweet\" data-url=\"https://seekingalpha.com/news/3254436-premarket-losers-of-9-05\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:17 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3254437\" data-ts=\"1490879725\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3254437-premarket-gainers-of-9-05\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers as of 9:05 am</a></h4><ul> <li><a href='https://seekingalpha.com/symbol/BVXV' title='Biondvax Pharmaceuticals'>BVXV</a> <font color='green'>+40%</font> on NIS 20M grant approval by Israel's Ministry of Economy and Industry.</li><li><a href='https://seekingalpha.com/symbol/IDXG' title='Interpace Diagnostics Group, Inc.'>IDXG</a> <font color='green'>+36%</font> on Q4 earnings.</li><li><a href='https://seekingalpha.com/symbol/EXTR' title='Extreme Networks, Inc.'>EXTR</a> <font color='green'>+21%</font> on buying the data-center networking business from Brocade.</li><li><a href='https://seekingalpha.com/symbol/PRAN' title='Prana Biotechnology Ltd'>PRAN</a> <font color='green'>+19%</font>.</li><li><a href='https://seekingalpha.com/symbol/MYSZ' title='MySize Inc.'>MYSZ</a> <font color='green'>+18%</font>.</li><li><a href='https://seekingalpha.com/symbol/SRAX' title='Social Reality Inc.'>SRAX</a> <font color='green'>+12%</font>.</li><li><a href='https://seekingalpha.com/symbol/AEZS' title='AEterna Zentaris, Inc.'>AEZS</a> <font color='green'>+10%</font>.</li><li><a href='https://seekingalpha.com/symbol/AKER' title='Akers Biosciences Inc.'>AKER</a> <font color='green'>+10%</font> on preliminary FY2016 earnings.</li><li><a href='https://seekingalpha.com/symbol/COP' title='ConocoPhillips'>COP</a> <font color='green'>+7%</font> on sale of 50% interest in the Foster Creek Christina Lake partnership to Cenovus Energy.</li><li><a href='https://seekingalpha.com/symbol/HTGM' title='HTG Molecular Diagnostics'>HTGM</a> <font color='green'>+6%</font>.</li><li><a href='https://seekingalpha.com/symbol/OMER' title='Omeros Corporation'>OMER</a> <font color='green'>+6%</font> on positive       data from the company&rsquo;s Phase 2 clinical trial of OMS721 for the       treatment of serious kidney disorders.</li><li>ITEK <font color='green'>+5%</font>.</li><li><a href='https://seekingalpha.com/symbol/SMRT' title='Stein Mart, Inc.'>SMRT</a> <font color='green'>+5%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3254437\" data-linked=\"Premarket Gainers as of 9:05 am\" data-tweet=\"$BVXV $IDXG $EXTR - Premarket Gainers as of 9:05 am https://seekingalpha.com/news/3254437-premarket-gainers-of-9-05?source=tweet\" data-url=\"https://seekingalpha.com/news/3254437-premarket-gainers-of-9-05\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:15 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3254433\" data-ts=\"1490879051\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UNXL\" target=\"_blank\">UNXL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3254433-new-design-win-for-unipixelplus-2-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">New design win for UniPixel; +2% premarket</a></h4><ul><li><a href=\"http://finance.yahoo.com/news/unipixel-awarded-10-1-inch-120100461.html\" target=\"_blank\">The company reports an</a> award for a 10.1\" active stylus enabled tablet program from a \"major Japan-based PC manufacturer.\"</li><li>Volume production is expected to start in H2.</li><li>UniPixel (NASDAQ:<a href='https://seekingalpha.com/symbol/UNXL' title='Uni-Pixel, Inc.'>UNXL</a>) reports its Q4 after the close today.</li><li>Shares&nbsp;<font color='green'>+2.4%</font>&nbsp;premarket</li></ul><div class=\"tiny-share-widget\" data-id=\"3254433\" data-linked=\"New design win for UniPixel; +2% premarket\" data-tweet=\"$UNXL - New design win for UniPixel; +2% premarket https://seekingalpha.com/news/3254433-new-design-win-for-unipixelplus-2-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3254433-new-design-win-for-unipixelplus-2-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:04 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3254428\" data-ts=\"1490878817\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HALO\" target=\"_blank\">HALO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3254428-halozymes-pegph20-shows-no-incremental-survival-benefit-in-pancreatic-cancer-study-shares\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Halozyme&#39;s PEGPH20 shows no incremental survival benefit in pancreatic cancer study; shares down 11% premarket</a></h4><ul><li>Halozyme (NASDAQ:<a href='https://seekingalpha.com/symbol/HALO' title='Halozyme Therapeutics, Inc.'>HALO</a>) slumps&nbsp;<font color='red'>11%</font>&nbsp;premarket on average volume in response to its <a href=\"https://seekingalpha.com/pr/16785544-halozyme-provides-update-swog-collaborative-group-clinical-study\" target=\"_blank\">announcement </a>that a Phase 1b/2 clinical trial assessing PEGPH20, plus modified FOLFIRINOX chemotherapy, in treatment-naive patients with metastatic pancreatic cancer would be unlikely to show an increase in overall survival (the primary endpoint) compared to FOLIFIRINOX alone. The assessment was made by an independent network of researchers called SWOG.</li><li>The company is working with SWOG to verify and analyze the data, including an analysis of hyaluronan &#40;HA&#41; level, following the determination of the tumor HA levels.</li><li><a href=\"http://www.halozyme.com/technology-and-products/product-candidate/pegph20/default.aspx\" target=\"_blank\">PEGPH20</a>&nbsp;is an investigational drug administered intravenously that temporarily degrades HA.</li></ul><div class=\"tiny-share-widget\" data-id=\"3254428\" data-linked=\"Halozyme&#39;s PEGPH20 shows no incremental survival benefit in pancreatic cancer study; shares down 11% premarket\" data-tweet=\"$HALO - Halozyme&#39;s PEGPH20 shows no incremental survival benefit in pancreatic cancer study; shares down 11% premarket https://seekingalpha.com/news/3254428-halozymes-pegph20-shows-no-incremental-survival-benefit-in-pancreatic-cancer-study-shares?source=tweet\" data-url=\"https://seekingalpha.com/news/3254428-halozymes-pegph20-shows-no-incremental-survival-benefit-in-pancreatic-cancer-study-shares\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:00 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3254423\" data-ts=\"1490878645\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/X\" target=\"_blank\">X</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3254423-u-s-steel-arcelormittal-move-higher-amid-analyst-praise\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">U.S. Steel, ArcelorMittal move higher amid analyst praise</a></h4><ul><li>Steel names are higher in premarket action after three major metals teams are out with positive sector calls.</li><li>U.S. Steel (NYSE:<a href='https://seekingalpha.com/symbol/X' title='United States Steel Corporation'>X</a>)&nbsp;<font color='green'>+1.8%</font> premarket after Jefferies <a href=\"https://twitter.com/thenotablecalls/status/847423964531965953\" target=\"_blank\">raises its stock price target to $50</a> from $45 and maintains a Buy rating amid a positive steel analysis, predicting the company will guide 2017 EBITDA of $1.4B-$1.8B vs. Wall Street consensus of $1.25B.</li><li>ArcelorMittal (NYSE:<a href='https://seekingalpha.com/symbol/MT' title='ArcelorMittal'>MT</a>)&nbsp;+1.3% after Bank of America suggests a buy opportunity, saying the stock could be <a href=\"https://twitter.com/thenotablecalls/status/847422616755453952\" target=\"_blank\">worth as much as $16-plus</a>, as margins have recovered sharply and the macro environment looks very supportive.</li><li>Morgan Stanley also sees a <a href=\"https://twitter.com/thenotablecalls/status/847422573822345218\" target=\"_blank\">potential re-rating</a> of the European metals and mining space.</li></ul><div class=\"tiny-share-widget\" data-id=\"3254423\" data-linked=\"U.S. Steel, ArcelorMittal move higher amid analyst praise\" data-tweet=\"$X $X $MT - U.S. Steel, ArcelorMittal move higher amid analyst praise https://seekingalpha.com/news/3254423-u-s-steel-arcelormittal-move-higher-amid-analyst-praise?source=tweet\" data-url=\"https://seekingalpha.com/news/3254423-u-s-steel-arcelormittal-move-higher-amid-analyst-praise\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:57 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3254421\" data-ts=\"1490878342\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CYBR\" target=\"_blank\">CYBR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3254421-cyberark-gets-2nd-upgrade-in-2-daysplus-3_7\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CyberArk gets 2nd upgrade in 2 days; +3.7%</a></h4><ul><li>Calling the CyberArk (NASDAQ:<a href='https://seekingalpha.com/symbol/CYBR' title='CyberArk Software Ltd.'>CYBR</a>) \"one of the best secular growth stories in security today,\" Goldman's&nbsp;Gabriela Borges upgrades to Buy from Neutral.</li><li>The $64 price target suggests more than&nbsp;<font color='green'>25% upside</font>.</li><li>She expects a series of \"beat and raise\" quarters as&nbsp;privileged access becomes a higher priority in cybersecurity spending for large enterprises.</li><li>Boosted adoption from Europe should also be a plus.</li><li>Source: Bloomberg</li><li>Shares&nbsp;<font color='green'>+3.7%</font>&nbsp;to $52 premarket</li><li>Previously: <a href=\"https://seekingalpha.com/news/3254097-cyberark-software-plus-1_4-percent-evercore-buys-dip\" target=\"_blank\">Cyberark Software +1.4% as Evercore buys the dip</a> (March 29)</li></ul><div class=\"tiny-share-widget\" data-id=\"3254421\" data-linked=\"CyberArk gets 2nd upgrade in 2 days; +3.7%\" data-tweet=\"$CYBR - CyberArk gets 2nd upgrade in 2 days; +3.7% https://seekingalpha.com/news/3254421-cyberark-gets-2nd-upgrade-in-2-daysplus-3_7?source=tweet\" data-url=\"https://seekingalpha.com/news/3254421-cyberark-gets-2nd-upgrade-in-2-daysplus-3_7\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:52 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3254418\" data-ts=\"1490877996\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TNXP\" target=\"_blank\">TNXP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3254418-tonix-pharma-prices-stock-offering-4_45-shares-down-14-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tonix Pharma prices stock offering at $4.45; shares down 14% premarket</a></h4><ul><li>Tonix Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/TNXP' title='Tonix Pharmaceuticals Holding Corp.'>TNXP</a>) slumps&nbsp;<font color='red'>14%</font>&nbsp;premarket on robust volume in response to the <a href=\"https://seekingalpha.com/pr/16785456-tonix-pharmaceuticals-prices-public-offering-1800-000-shares-common-stock\" target=\"_blank\">pricing </a>of its public offering of 1.8M shares of common stock at $4.45. Underwriters over-allotment is an additional 270K shares. Closing date is April 4.</li><li>Net proceeds will fund the continued development of TNX-102 SL for PTSD, other pipeline programs, working capital and general corporate purposes.</li><li>Yesterday's close was $5.55.</li></ul><div class=\"tiny-share-widget\" data-id=\"3254418\" data-linked=\"Tonix Pharma prices stock offering at $4.45; shares down 14% premarket\" data-tweet=\"$TNXP - Tonix Pharma prices stock offering at $4.45; shares down 14% premarket https://seekingalpha.com/news/3254418-tonix-pharma-prices-stock-offering-4_45-shares-down-14-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3254418-tonix-pharma-prices-stock-offering-4_45-shares-down-14-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:46 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3254401\" data-ts=\"1490876483\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LULU\" target=\"_blank\">LULU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3254401-analyst-pessimism-rains-down-on-lululemon\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Analyst pessimism rains down on Lululemon</a></h4><ul> <li>Analysts are reacting to the weak guidance pushed out by Lululemon (NASDAQ:<a href='https://seekingalpha.com/symbol/LULU' title='Lululemon Athletica Inc.'>LULU</a>) yesterday alongside its Q4 earnings report.</li> <li>Citi lowers Lululemon to Neutral from Buy on concerns over the productivity comparisions that are upcoming.</li> <li>Wells Fargo moves to Market Perform from Outperform to adjust valuation to the profit guidance from the company. Concerns over margins are raised.</li> <li>Bank of America Merrill Lynch cuts LULU to Underperform from Neutral and chops its price target down to $57. \"Slowing sales and moderating [gross margins] puts bull thesis on the mat,\" says analyst Ira Boruchow.</li> <li>Susquehanna takes the retailer to Neutral from Positive and comes in with a $57 PT.</li> <li>Canaccord takes a victory lap with its Sell rating on LULU into the print looking solid. Analyst Camilo Lyons calls the assortment failure at Lululemon particularly surprising.</li> <li>Sources: Bloomberg<a href=\"https://twitter.com/thenotablecalls\" target=\"_blank\">, Notable Calls</a> and <a href=\"http://www.marketwatch.com/story/lululemons-stock-plunges-toward-biggest-loss-in-over-8-years-as-analysts-cut-ratings-targets-2017-03-30\" target=\"_blank\">MarketWatch</a>.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3254262-lululemon-athletica-misses-0_01-beats-revenue\" target=\"_blank\">Lululemon Athletica misses by $0.01, beats on revenue</a> (March 29)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3254270-tailspin-lululemon-warning-slow-start-2017\" target=\"_blank\">Tailspin for Lululemon after warning on 'slow start' to 2017</a> (March 29)</li> <li>LULU <font color='red'>-20.30%</font> premarket to $52.84 (52-week low).</li> </ul><div class=\"tiny-share-widget\" data-id=\"3254401\" data-linked=\"Analyst pessimism rains down on Lululemon\" data-tweet=\"$LULU - Analyst pessimism rains down on Lululemon https://seekingalpha.com/news/3254401-analyst-pessimism-rains-down-on-lululemon?source=tweet\" data-url=\"https://seekingalpha.com/news/3254401-analyst-pessimism-rains-down-on-lululemon\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:21 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3254389\" data-ts=\"1490874888\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TITN\" target=\"_blank\">TITN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3254389-on-titan-machinerys-q4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Titan Machinery&#39;s Q4</a></h4><ul>     <li>Titan Machinery (NASDAQ:<a href='https://seekingalpha.com/symbol/TITN' title='Titan Machinery Inc.'>TITN</a>) reports equipment revenue fell 6.9% to $226.9M in <a href=\"https://seekingalpha.com/pr/16785263-titan-machinery-inc-announces-results-fiscal-fourth-quarter-fiscal-year-ended-january-31-2017\" target=\"_blank\">Q4</a>.</li>     <li>Parts revenue up 1.7% to $48.7M and service revenue +1.4% to $28M.</li>     <li>Segment revenue: Agriculture: $201.1M (-1.5%); Construction: $81.7M (-10.5%); International: $34.8M (-12.8%).</li>     <li>Gross margin rate improved 1060 bps to 15.4%.</li>     <li>Operating expense rate grew 10 bps to 16.4%.</li>     <li><b>FY2018 Guidance</b>:&nbsp;Agriculture sales: -10% to -15%;&nbsp;Construction sales: -5% to -10%;&nbsp;International sales: +3% to +8%; Equipments margins: 6.3% to 6.8%; Diluted EPS: slightly positive.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3254389\" data-linked=\"More on Titan Machinery&#39;s Q4\" data-tweet=\"$TITN - More on Titan Machinery&#39;s Q4 https://seekingalpha.com/news/3254389-on-titan-machinerys-q4?source=tweet\" data-url=\"https://seekingalpha.com/news/3254389-on-titan-machinerys-q4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:54 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3254355\" data-ts=\"1490874142\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CAAS\" target=\"_blank\">CAAS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3254355-on-china-automitive-systems-q4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on China Automitive System&#39;s Q4</a></h4><ul><li>China Automotive Systems (NASDAQ:<a href='https://seekingalpha.com/symbol/CAAS' title='China Automotive Systems, Inc.'>CAAS</a>)&nbsp;reports sales rose 24.6% in <a href=\"https://seekingalpha.com/pr/16785223-china-automotive-systems-reports-fourth-quarter-fiscal-2016-results\" target=\"_blank\">Q4</a> mainly due to increased auto sales and a shift in the product mix to more electric power steering products.</li><li>Gross margin rate squeezed 220 bps to 14.6% due to the impact of recalls by two customers related to the Company's products in January 2017.</li><li>Selling expense rate reamained constant at 3.3%.</li><li>Operating margin rate fell 260 bps to 3.3%.</li><li>The company expects FY2017 revenue of $485M.</li></ul><div class=\"tiny-share-widget\" data-id=\"3254355\" data-linked=\"More on China Automitive System&#39;s Q4\" data-tweet=\"$CAAS - More on China Automitive System&#39;s Q4 https://seekingalpha.com/news/3254355-on-china-automitive-systems-q4?source=tweet\" data-url=\"https://seekingalpha.com/news/3254355-on-china-automitive-systems-q4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:42 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3254377\" data-ts=\"1490873426\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CY\" target=\"_blank\">CY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3254377-cypress-semi-downgraded-to-underweight-morgan-stanley-sharesminus-1_7\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cypress Semi downgraded to Underweight at Morgan Stanley; shares -1.7%</a></h4><ul><li>Despite lower gross margins, Cypress Semiconductor (NASDAQ:<a href='https://seekingalpha.com/symbol/CY' title='Cypress Semiconductor Corporation'>CY</a>) trades at a premium to peers, says analyst Craig Hettenbach, downgrading to Underweight from Equal Weight. His $12 price target remains.</li><li>Cypress currently sells fro a P/E ratio of 18x, he says, a 16% premium to Microchip Technology (NASDAQ:<a href='https://seekingalpha.com/symbol/MCHP' title='Microchip Technology Incorporated'>MCHP</a>), and a 12% premium to Analog Devices (NASDAQ:<a href='https://seekingalpha.com/symbol/ADI' title='Analog Devices Inc.'>ADI</a>).</li><li>Shares&nbsp;<font color='red'>-1.7%</font>&nbsp;premarket to $14.</li></ul><div class=\"tiny-share-widget\" data-id=\"3254377\" data-linked=\"Cypress Semi downgraded to Underweight at Morgan Stanley; shares -1.7%\" data-tweet=\"$CY $CY $MCHP - Cypress Semi downgraded to Underweight at Morgan Stanley; shares -1.7% https://seekingalpha.com/news/3254377-cypress-semi-downgraded-to-underweight-morgan-stanley-sharesminus-1_7?source=tweet\" data-url=\"https://seekingalpha.com/news/3254377-cypress-semi-downgraded-to-underweight-morgan-stanley-sharesminus-1_7\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:30 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3254372\" data-ts=\"1490872702\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OCSL\" target=\"_blank\">OCSL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3254372-fifth-street-financeminus-2-after-downgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fifth Street Finance -2% after downgrade</a></h4><ul><li>Raymond James' <a href=\"https://www.streetinsider.com/Analyst+Comments/Raymond+James+Downgrades+Fifth+Street+Finance+%28FSC%29+to+Underperform/12722348.html\" target=\"_blank\">Robert Dodd downgrades</a> Fifth Street Finance (FSC) to Underperform from Market Perform. Prior to the move, FSC had 1 Buy and 9 Holds from the 10 sell-siders covering.</li><li>Shares&nbsp;<font color='red'>-2.1%</font>&nbsp;premarket</li></ul><div class=\"tiny-share-widget\" data-id=\"3254372\" data-linked=\"Fifth Street Finance -2% after downgrade\" data-tweet=\"$OCSL - Fifth Street Finance -2% after downgrade https://seekingalpha.com/news/3254372-fifth-street-financeminus-2-after-downgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3254372-fifth-street-financeminus-2-after-downgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:18 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>21&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3254363\" data-ts=\"1490871866\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BPMC\" target=\"_blank\">BPMC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3254363-blueprint-med-prices-stock-offering-40-shares-ease-2-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Blueprint Med prices stock offering at $40; shares ease 2% premarket</a></h4><ul><li>Blueprint Medicines (NASDAQ:<a href='https://seekingalpha.com/symbol/BPMC' title='Blueprint Medicines'>BPMC</a>) slips&nbsp;<font color='red'>2%</font>&nbsp;premarket, albeit on only 800 shares, after the company <a href=\"https://seekingalpha.com/pr/16785087-blueprint-medicines-announces-pricing-public-offering-shares-common-stock\" target=\"_blank\">announced </a>that it priced its public offering of 5M shares of common stock at $40 per share. Underwriters over-allotment is an additional 750K shares.</li><li>Yesterday's close was $41.24.</li></ul><div class=\"tiny-share-widget\" data-id=\"3254363\" data-linked=\"Blueprint Med prices stock offering at $40; shares ease 2% premarket\" data-tweet=\"$BPMC - Blueprint Med prices stock offering at $40; shares ease 2% premarket https://seekingalpha.com/news/3254363-blueprint-med-prices-stock-offering-40-shares-ease-2-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3254363-blueprint-med-prices-stock-offering-40-shares-ease-2-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:04 AM </div></div></li>","count":65,"message":null,"success":true,"today":{"start":1576990800,"end":1577077199,"str":"Sunday, December 22, 2019"},"yesterday":{"start":1576904400,"end":1576990799}}